Instability of an epigenetic mark: T-bet and STAT4 influence the symmetry and plasticity of DNA methylation at the IFN-\u3b3 promoter in effector and memory Th2 lymphocytes by Williams, Christopher Lawrence
 
 
INSTABILITY OF AN EPIGENETIC MARK: T-BET AND STAT4 INFLUENCE 
THE SYMMETRY AND PLASTICITY OF DNA METHYLATION AT THE  
IFNG PROMOTER IN EFFECTOR AND MEMORY TH2                                 
LYMPHOCYTES 
 
By Christopher L. Williams 
Dissertation 
Submitted to the Faculty of the 
Graduate School of Vanderbilt University 
in partial fulfillment of the requirements  
for the degree of 
DOCTOR OF PHILOSOPHY 
in 
Microbiology and Immunology 
August, 2013 
Nashville, TN 
Approved: 
Profesor Sebastian Joyce 
Professor James W. Thomas 
Professor Richard O’Brien 
Professor Earl Ruley 
Professor Mark Boothby 
 
 
 
 
 
 
 
 
 
 
Copyright © 2013 by Christopher Lawrence Williams 
All Rights Reserved 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
To Laura and my parents  
  
iv 
 
 
ACKNOWLEDGEMENTS 
 This work was funded by the Molecular Endocrinology Training Grant (T32 
DK07563) and by NIH research grant RO1 AI077528 (to M.B.).  
 I would like to thank Mark Boothby, my dissertation advisor, and the members of 
my dissertation committee: Sebastian Joyce, James W. Thomas, Richard O’Brien, and 
Earl Ruley.  Without their guidance and dedication this would not have been possible, 
and I am eternally grateful that they never gave up on me.   
 My coworkers past and present have provided me both with technical support and 
insights into how to be a better scientist.  I am especially grateful to Aditi, Keunwook 
Lee, Sung Hoon Cho, Marcia Shilling, and Mei Wei for their help at various stages of my 
work.     
 I owe a debt of gratitude to the many friends I have made here in Nashville.  They 
have made Nashville feel like home and provided a great and truly unique support 
network.       
 I would like to thank my family.  Thank you, Mom and Dad.  You gave me a love 
of learning and the means to pursue it.  I would also like to thank  the Zierolf family for 
welcoming me.  Finally, I am truly grateful to Laura, my wife, without whom I never 
would have come this far. 
  
v 
 
TABLE OF CONTENTS 
 
Page 
DEDICATION……………………………….…………………………………………...iii 
ACKNOWLEDGEMENTS………………………………………………………………iv 
LIST OF TABLES  ...…………………………………………………………………....vii 
LIST OF FIGURES ....…...……………………………………………………………..viii 
LIST OF ABBREVIATIONS ……………………………………………………….........x 
 
Chapter 
I. INTRODUCTION ............................................................................................1 
 
T cell ontogeny: Thymic development ......……………………........….....3 
Thymic development: Insights from transgenic mouse models .…........…5 
Thymic development: MHC specificity and coreceptor selection .....……7 
NKT cells: Lipid reactive T cells …………………....…………….....…..9 
T helper subsets: General …………………………....…………........….10 
T cell activation: TCR signaling .…………………....…….....….......…..16 
T cell activation: Costimulators and co-repressors ...……........…........…19 
Differentiation of naïve CD4+ cells into effector subsets..........:................. 
Cytokine signaling....................................................................................23 
Cytokine signaling: Th1 development ......................................................24 
Cytokine signaling: Th2 development ......................................................27 
T cell activation and differentiation ..........................................................28 
Epigenetics and transcription in cytokine genes .......................................30 
Regulation of the transcription of Ifng and Th2 cytokine genes in primary 
effectors: The Ifng gene ............................................................................35 
Regulation of the transcription of Ifng and Th2 cytokine genes in primary 
effectors: The Th2 cytokine locus .............................................................38 
T cell memory ......................................................................................... 39 
Regulation of cytokine genes in the memory phase .................................43 
Regulation of cytokine genes in the memory phase: Flexibility ..............44 
 
II. HEMIMETHYLATION OF THE Ifng PROMOTER IN TH2 EFFECTOR  
CELLS .......................................................................................................46 
 
Strand-biased acquisition of Ifng promoter methylation in Th2 effector..... 
cells ...........................................................................................................46 
SnaBI digestion is sensitive to hemimethylation ......................................54 
vi 
 
Asymmetrical methylation impacts transcription factor binding to the Ifng 
promoter ....................................................................................................56 
CREB1 and the Ifng promoter ..................................................................62 
Conclusions ...............................................................................................67 
 
III. REGULATION OF IFN-γ PRODUCTION IN Th2 MEMORY CELLS ......68 
 
Absence of promoter methylation in Th2-derived memory cells .............68 
Requirement for STAT4 in flexible production of IFN-γ .........................75 
Stat4-deficient cells have normal T-bet induction and homeostatic.............. 
expansion  .................................................................................................80 
Alterations in CpG methylation in Tbx21-/- and Stat4 -/- Th2 effector........  
and memory cells ......................................................................................83 
Exogenous expression of T-bet in Tbx21-/- Th2 effector and Th2 memory. 
cells ...........................................................................................................87 
Conclusions ...............................................................................................91 
 
IV. DISCUSSION AND FUTURE DIRECTIONS ..............................................92 
 
Cells are flexible, genes are plastic ...........................................................94 
Phenotypic plasticity and cancer ...............................................................95 
Induction of plasticity: Transdifferentiation and dedifferentiation .........96 
An extra layer of adaptability: Why might this reprograming exist?.......99 
DNA methylation, cytokine expression, and memory ............................101 
Future directions: flexible IFN-γ production and the antibody response.....  
................................................................................................................103 
Future directions: methylation vs. hydroxymethylation .........................108 
 
V. MATERIALS AND METHODS ..................................................................110 
REFERENCES .........................................................................................................117 
 
  
vii 
 
LIST OF TABLES 
 
Table                                                                                                                         Page 
2.1 CpG methylation in naïve CD4+ T cells, thymus, brain, and NIH 3T3 cells .......51 
5.1 Sequences of oligonucleotides ............................................................................113 
 
  
viii 
 
LIST OF FIGURES 
 
 Figure                                                                                                                      Page 
Figure 1.1.. Th1 and Th2 development following antigen stimulation ......................12 
Figure 1.2 Master regulators and STATs drive T helper polarization ........................25 
 Figure 1.3 IL-12 signaling by STAT4-dependent and independent mechanisms......26 
Figure 1.4.  Alternative models of T cell memory.......................................................42 
Figure 2.1. Bisulfite modification for the detection of CpG methylation...................48 
Figure 2.2.  Methylation of the Ifng promoter is lineage-specific...............................49 
Figure 2.3. Asymmetric methylation of the Ifng promoter in Th2 effectors..............50 
Figure 2.4. Th2 effectors have exited cell cycle at the time of DNA methylation.........  
analysis ........................................................................................................................53 
Figure 2.5. SnaBI digestion is inhibited by hemimethylation at C-53 .......................55 
Figure 2.6.  Inhibition of protein-DNA interaction by hemimethylation ...................57 
Figure 2.7. Effects of hemimethylation on protein-binding affinity ...........................58 
Figure 2.8. Calculation of relative affinities of unmethylated and C-53......................... 
hemimethylated (1xMe) probe ....................................................................................59 
Figure 2.9. Identification of the slower migrating band as a CREB1 containing........... 
complex .......................................................................................................................61 
Figure 2.10. CREB1 is recruited to the Ifng promoter in Th1, but not Th2 cells .......64 
Figure 2.11. CREB1 can transactivate a minimal Ifng promoter.................................65  
Figure 2.12: Dibutyrl-cAMP driven inhibition of Ifng promoter activity is blocked by 
exogenous CREB1 expression ....................................................................................66 
Figure 3.1. Generation of memory cells from IL-4 producing Th2 effectors .............69 
Figure 3.2. Homeostatic expansion in BALB/c and BALB/c Nude recipients...........70 
Figure 3.3.  IFN-γ production in Th2-derived memory cells ......................................71 
Figure 3.4.  Absence of coding strand methylation in memory Th2 cells ..................72 
Figure 3.5.  Quantification of methylation of the Ifng promoter in Th2-derived...........  
memory cells ..............................................................................................................73 
ix 
 
Figure 3.6. A model of cell division dependent passive demethylation .....................74 
Figure 3.7. IFN-γ secretion is impaired in T-bet or STAT4 deficient Th2-derived.......     
memory cells ...............................................................................................................77 
Figure 3.8. IFN-γ production of T-bet or STAT4-deficient Th2 memory cells.............. 
relative to wildtype Th2 memory cells........................................................................78 
Figure 3.9.  Intracellular cytokine staining of T-bet-deficient, STAT4-deficient,......... 
and wildtype Th2-derived memory cells ....................................................................79 
Figure 3.10.T-bet induction and homeostatic expansion in STAT4-deficient Th2........ 
memory cells  ..............................................................................................................82 
Figure 3.11. Symmetry of methylation in Tbx21-/- and Stat4-/- Th2 effector............... 
cells........................................................................................................................... .84 
Figure 3.12. Alterations in DNA methylation in Tbx21l-/- or Stat4 -/-  Th2 memory.. 
cells .............................................................................................................................85 
Figure 3.13. Symmetrical methylation inhibits passive demethylation .....................86 
Figure 3.14.  T-bet transduced Tbx21-/-  Th2 effectors produce IFN-γ .....................89 
Figure 3.15. Production of IFN-γ by memory cells derived from T-bet transduced..... 
Tbx21-/- Th2 effector cells .........................................................................................90 
Figure 4.1. Timelineof antibody class switching experiment  .................................106 
Figure 4.2. Changes in NP-specific IgG2a one week after recall ............................107 
Figure 5.1.  Workflow for chromatin immunoprecipitation (ChIP) assay..............115 
  
x 
 
LIST OF ABBREVIATIONS 
 
3me-H3K4 – Histone 3 trimethylated on lysine 4 
Ac-H3(K9) – Histone 3 acetylated on lysine 9 
AKT/PKB – Protein kinase B 
APC – Antigen presenting cell 
APL – Altered peptide ligand 
Bcl – B cell lymphoma 
BCR – B cell receptor 
cAMP – Cyclic AMP 
CFDA-SE – 5 (and 6)-carboxyfluorescein diacetate-
succinimidyl ester 
ChIP – Chromatin immunoprecipitation 
CRE – Cyclic AMP response element 
CREB1 – cAMP response element binding protein 1 
CTL – Cytotoxic T lymphocyte 
CTLA-4 – Cytotoxic T lymphocyte antigen 4 
db-cAMP – Dibutyrl-cAMP  
DNMT –DNA methyltransferase 
FOXO1 – Forkhead box –containing O family 1 
GEF –Guanine exchange factor 
GFP – Green fluorescent protein 
ICOS – Inducible T cell costimulator 
Ifng –Interferon gamma gene 
IFN-γ – Interferon gamma protein 
IKK – IκB kinase 
IL-12Rβ – IL-12 receptor beta subunit 
IL-4  – Interleukin 4 
IRES –Internal ribosomal entry site 
ITAM – Immunoreceptor tyrosine-based activation 
motif 
IκB – Inhibitor of  NF-κB 
JAK – Janus kinase 
KO – Knockout   
LCR – Locus control region 
MAPK – Mitogen activated protein kinase 
me – methyl  
MHC – Major histocompatibility complex 
NFAT – Nuclear factor of activated T cells 
NF-κB – Nuclear factor kappa  
light polypeptide gene enhancer in B cells 
NKT cells – Natural killer T cells 
PAMP – Pathogen associated molecular pattern 
PI3K – Phosphatidylinositide 3-kinase  
PKA – Protein kinase A    
PKC – protein kinase C 
PLC – phospholipase C 
pMHC – Peptide containing MHC complex 
RAG – Recombination activating gene 
SCID – Severe combined immune deficiency 
SEM – Standard error of the mean 
SH2 – Src homology domain 2 
STAT – Signal transducer 
 and activator of transcription 
T-bet – T box expressed in T cells 
TCR –T cell receptor 
TFH – T follicular helper 
TGF-β – Transforming growth factor beta 
Th – T helper 
Treg – Regulatory T cells 
1 
 
I. INTRODUCTION 
The mammalian immune system has two main components: innate and adaptive. The 
innate immune system is composed of cells such as neutrophils, dendritic cells, natural 
killer (NK) cells, and macrophages.   These cells respond to broad categories of 
molecules such as double-stranded RNA and lipopolysaccharides via pathogen-associated 
molecular pattern (PAMP) receptors such as the Toll-like receptors (Medzhitov et al., 
1997; Rock et al., 1998, 1998), or the absence of MHC (major histocompatibility 
complex) class I on host cells (Santoli et al., 1978).  The adaptive component of the 
immune system allows for pathogen-specific responses based on the recognition of a 
specific molecule (Diener and Paetkau, 1972).  Some infectious challenges can be 
resolved by the innate system before the antigen level reaches a threshold that leads to the 
activation of the adaptive immune system.      
When the adaptive immune system is activated signals from the innate immune 
system are integrated by the cells of the adaptive immune system and are used to inform 
the development of an immune response tailored to the specific threat.  The adaptive 
immune system aids in pathogen clearance directly by mechanisms such as antibody 
production by B cells (Bjorneboe et al., 1947; Fagraeus, 1947; Harris et al., 1945) and the 
recognition and destruction of virus-infected cells by cytolytic (CD8
+
)  T cells (Berke and 
Amos, 1973; Lindahl and Wilson, 1977; Lohmann-Matthes and Fischer, 1973).   
Indirectly, cytokines produced by cells of the adaptive immune system serve to direct the 
responses of cells both in the adaptive and innate compartments of the immune system 
(Abbas et al., 1996; Dennert, 1974; Snapper and Paul, 1987). 
 Cells of the adaptive immune system detect their cognate antigen via an antigen 
receptor complex. These receptors include one or more constant subunits along with a  
heterodimer of variable chains, consisting of a heavy chain and light chain in the B cell 
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receptor (BCR) (Nemazee, 2000; Schatz et al., 1992).  In T cells the most often occurring 
subunits are the alpha and beta chains, although there is a proportionally smaller 
population defined by having a T cell receptor (TCR) composed of a gamma chain and a 
delta chain (Bluestone and Matis, 1989; Chien et al., 1987; Davis and Bjorkman, 1988).  
These receptor components are encoded by genes consisting of multiple gene segments 
that must be recombined to form a functioning receptor subunit (Alt et al., 1984, 1986; 
Schatz et al., 1992).  This rearrangement is primarily carried out by the enzymes RAG1 
and RAG2 along with multiple ligases and DNA repair enzymes (Schatz et al., 1989).  
Humans and mice deficient in enzymes required for receptor rearrangement cannot form 
B or T cells and are severely immune-compromised (Schuler et al., 1986), demonstrating 
the centrality of the antigen receptor to the adaptive immune response.  The joining of 
gene fragments to make a functional protein is random but always includes one V 
(variable) segment, one D (diversity) segment, and one J (joining) subunit (Alt et al., 
1986; Honjo et al., 1981; Schatz et al., 1992).  The junctions between the segments are 
composed of a variable number of nucleotides from each segment (Pollok et al., 1984; 
Schatz et al., 1992).  This variability increases the number of unique receptors that can be 
generated, but also creates the potential to create non-functioning genes by creating shifts 
in the reading frame (Pollok et al., 1984; Schatz et al., 1992).  The combinations of the V, 
D, and J transcriptional cassettes, along with their quasi-random joining allows for the 
generation of an almost infinite number of unique antigen receptors.  This means that a 
given pathogen, introducing multiple antigens, will only activate a fraction of the antigen 
receptors in the host repertoire.  This diversity of receptor specificity gives rise to the 
adaptive immune system’s ability to treat one antigen differently from another, and thus 
be adaptive.   
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T cell ontogeny: Thymic development 
T cells are a leukocyte population that matures from hematopoietic stem cells in 
the thymus.  Unlike the B cell receptor, the T cell receptor can only recognize its cognate 
antigen in the context of an MHC.  Due to the random generation of TCRα and TCRβ 
chains, it is likely that many generated TCRs will not be able to interact with or 
‘recognize’ host MHC molecules (Alt et al., 1986; Pollok et al., 1984).  This random 
generation also entails that many TCRs generated will recognize epitopes belonging to 
the host in the context of MHCs (Alt et al., 1986; Kappler et al., 1987; Klein et al., 2009).  
The development of T cells in the thymus, termed thymic education, serves to minimize 
the impact of non-reactive and auto-reactive clones.   
Immature cells begin as CD4
-
, CD8
-
 thymocytes lacking a T cell receptor (Ikuta 
et al., 1992; Shortman and Wu, 1996).  During the course of development these double-
negative thymocytes rearrange the TCRβ gene to form a functioning beta chain of the T 
cell receptor.  A functioning TCRβ molecule will form a complex with CD3 molecules, 
the invariant TCRζ chain, and an invariant pre-TCRα chain.  Signaling through this pre-T 
cell receptor leads to clonal expansion, expression of the co-receptors CD4 and CD8, and 
initiation of TCRα rearrangement (Starr et al., 2003).  Double-positive (CD4
+
,CD8
+
) 
thymocyte survival is dependent first on assembling a functional TCRα chain that will 
form an MHC-restricted dimer with the expressed TCRβ chain.  The TCRα 
rearrangement is started with the J fragments at the 5’ end of the locus and proceeds to 
the 3’ end.  This allows multiple recombinations of the TCRα gene to occur, with the 
rearrangements only ceasing after the successful generation of an MHC-recognizing TCR 
or upon cell death.  The proliferation after pre-TCR signaling along with the multiple 
attempts at rearranging the TCRα gene allowes each cell to maximize the possibility of a 
successful TCRβ rearrangement leading to the generation of at least one functional TCR 
(Petrie et al., 1993).   
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The generation of a functioning TCR is required for T cell survival, but it is not 
sufficient.  Further developmental checkpoints must be passed before thymic education is 
complete. Signaling from a functional TCRα/β dimer-containing receptor interacting with 
an MHC-peptide (pMHC) complex protects against apoptosis in a process termed 
positive selection (Borgulya et al., 1992; Jameson et al., 1995; Starr et al., 2003).  Cells 
failing to achieve positive selection eventually undergo death by neglect.  Cells that have 
undergone positive selection repress the expression of RAG1/2 (Brändle et al., 1992), and 
restrict themselves to either CD4 or CD8 expression, depending on which class of MHC 
the TCR recognized (Hogquist et al., 1993; Jameson et al., 1995; MacDonald et al., 1988; 
Starr et al., 2003).  This cessation of recombination means that the vast majority of T 
cells generated will express only one TCR, and thus have a single specificity.  The single 
antigen-specificity of each TCR has important ramifications on the development of 
prophylactic immune responses that will be discussed later in this work.   While the 
ability to recognize an MHC is required for survival and further development, more 
screening must be carried out in the thymus. 
The random generation of TCRs means that some TCRs will react strongly to 
self-antigens in the context of MHCs.  In order to prevent auto-immunity, T cells are also 
screened for reactivity for self-antigens.  Cells with TCRs that bind with high affinity to 
self-pMHC complexes are either deleted from the repertoire in a process termed negative 
selection (Guidos et al., 1990; Kappler et al., 1987; Sha et al., 1988) or are induced into 
becoming natural T regulatory cells (Kawahata et al., 2002; Liston et al., 2008).  The 
deletion of auto-reactive clones is accomplished by an active process involving the 
induction of apoptotic pathways (Guidos et al., 1990; Schönrich et al., 1993; Sha et al., 
1988).  Both positive and negative selection require an interaction between the antigen 
receptor and self-antigens in the context of MHC.  As this became evident, it was 
hypothesized that the difference between TCR signaling in positive selection and 
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negative selection was due to the affinity of a TCR for a pMHC expressed in the thymus 
(Ashton-Rickardt et al., 1994; Sebzda et al., 1994).  Alternatively, it was hypothesized 
that peptides displayed within the thymus were different than those encountered 
elsewhere (Moran and Hogquist, 2012), although further research found that this was not 
likely (Hogquist et al., 1997; Lo et al., 2009; Marrack et al., 1993; Moran and Hogquist, 
2012).   One powerful tool used to test the affinity hypothesis was the use of mice 
expressing transgenic TCRs.    
 
Thymic development: Insights from transgenic TCR models  
The number of different TCRs being generated and tested in the thymus raises 
significant problems in investigating how a TCR’s interaction with self-antigen-MHC 
complexes regulates its survival and development.  To circumvent this, successfully 
recombined Tcra and Tcrb genes were inserted into a host genome.  This allows for the 
majority of T cells to express the same TCR.   These transgenic TCR models have been 
used to investigate the role of TCR signaling in T cell development (von Boehmer, 1990; 
Jameson et al., 1995; Starr et al., 2003).  Transgenic systems have been used to 
investigate the effects of antigen concentration and affinity on thymic development.  
Commonly, the transgenic TCR’s antigen and MHC specificity is known, allowing for 
the stimulation of the receptor by its cognate antigen.  The use of peptide-specific TCR 
transgenic mice has been a powerful tool in understanding TCR signaling in positive and 
negative selection.   
  Studies using an MHC class I-restricted transgenic TCR provided key initial 
insights into role of concentration in thymic selection.  The addition of a low 
concentration of cognate antigen to thymocytes from a TCR transgenic mouse was found 
to induce positive selection, whereas a higher concentration induced negative selection 
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(Ashton-Rickardt et al., 1994; Sebzda et al., 1994).  Furthermore, changing residues of 
the antigen peptide that contact the TCR was found to alter the response of thymocytes 
(Evavold et al., 1993; Nicholson et al., 1995).   Interestingly, it was also found that some 
agonist could promote positive selection across a range of concentrations, but were 
unable to trigger negative selection (Kraj et al., 2001; Sebzda et al., 1996).  Taken 
together, these results suggested that affinity of a ligand for a TCR, as well as the 
concentration, was important for determining the response of thymocytes to antigen.       
 The known antigen specificity of transgenic TCRs allowed for investigation into 
the effects of a TCR’s affinity for its cognate pMHC specifically via the use of altered 
peptide ligands (APL).  The alteration of one or more residues of a TCR’s cognate 
peptide to increase or decrease its binding affinity for the TCR has been shown to 
produce profound effects on the development of transgenic TCR-expressing T cells (Hsu 
et al., 1995; Sebzda et al., 1994).  The effect of these altered peptide ligands depends on 
several variables such as the location of expression within the thymus, the concentration 
of ligand used (Alam et al., 1996; Sebzda et al., 1994), and which population of thymic 
cells presents the antigen (Aschenbrenner et al., 2007), but a few key principles can be 
simply articulated.  Introduction of a high-affinity peptide into the thymic environment 
leads to an increase in negative selection of TCR transgenic cells in many cases, but 
exceptions have been reported (Ashton-Rickardt et al., 1994; Kraj et al., 2001; Moran and 
Hogquist, 2012; Spain et al., 1994).  Conversely, low affinity ‘antagonist’ peptides has 
been demonstrated to promote the positive selection of thymocytes (Alam et al., 1996; 
Hogquist et al., 1994, 1997; Hu et al., 1997).  The interplay between antigen density and 
antigen affinity also has significant impact, as a low affinity antigen may be positively 
selecting at high concentrations, but not at lower concentrations (Liu et al., 1998a).   
Further work showed that the time a thymocyte spent in contact with a thymic 
antigen presenting cell (APC) had a strong predictive value as to whether it would 
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undergo positive or negative selection (Williams et al., 1999). The duration of            
APC-T cell interaction also was found to be a determining factor in whether a presented 
antigen induced activation or tolerance (Katzman et al., 2010)  Combined with the 
observations about the effects of ligand concentration and affinity, this suggest a model in 
which the strength of and number of pMHC-TCR interactions determines binding time, 
and therefore cell survival and function upon antigen recognition in the periphery.  .  
Interestingly, recent work has demonstrated that the signaling strength of TCRs after 
exposure to self-pHMC during thymic education correlates with its strength of signaling 
upon exposure to its cognate exogenous antigen (Mandl et al., 2013).  This suggests that 
positive selection can also serve to promote the survival of cells which will respond most 
vigorously to pathogens (Mandl et al., 2013).          
To summarize: A TCR bound with high affinity to a pMHC signals through 
pathways that are not engaged by the lower affinity interactions leading to positive 
selection (Morris and Allen, 2012).  T cell survival is dictated by the ability of a TCR to 
react to MHC/self-peptide complexes at a much lower signaling intensity than is seen in 
T cells responding to their cognate exogenous antigen (Ashton-Rickardt et al., 1994; Starr 
et al., 2003).  To pass through thymic education with the potential to become an effector 
T cell, a TCR’s affinity for self-pMHC must fall within certain tolerances. 
   
Thymic development: MHC specificity and coreceptor selection 
As previously discussed, a key requirement of thymic education is the recognition 
of self-peptides in the context of an MHC molecule.  There are two predominant types of 
MHC, MHC class I and MHC class II (Benacerraf, 1988; Braciale et al., 1987).  Each 
MHC type samples peptides derived from different cellular processes although there are 
mechanisms that allow for cross-presentation (Joffre et al., 2012; Rock et al., 2010).  
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MHC class I molecules are expressed on most cell types and primarily present peptides 
derived from proteins created by the MHC class I-bearing cell (Apcher et al., 2012; 
Procko and Gaudet, 2009; Vigneron and Van den Eynde, 2012).  Production of proteins 
due to viral infection or mutation will create non-self-antigens detectable by T cells.  
MHC class II molecules are displayed on antigen presenting cells of the immune system 
such as macrophages, dendritic cells, and B cells.  These molecules typically display 
peptides derived from proteins taken up from the local environment, such as those found 
on a phagoctyosed bacterium (Goldszmid and Sher, 2010; Ramachandra et al., 2009).  
Further studies would determine that a TCR’s specificity goes beyond the class of MHC 
it recognizes.   
The use of a transgenic TCR with a known MHC requirement allowed for the 
investigation of the role of MHC expression in T cell development(von Boehmer, 1990).  
One key experiment involved placing thymocytes expressing a TCR reactive to antigen in 
the context of one MHC II allele into cultures of cell expressing other MHC class II 
alleles.  This experiment demonstrated that recognition of the host MHC by a TCR was 
required for positive selection and development past the CD4
+
,
 
CD8
+
 double-positive 
stage (Berg et al., 1990).  Furthermore, the use of an MHC class I restricted transgenic 
TCR in CD8-deficient animals was found to lead to deficiencies in T cell development 
(von Boehmer, 1990; Jameson et al., 1995; Killeen et al., 1992; Schönrich et al., 1993). 
MHC molecules are recognized by the coreceptors CD4 and CD8.  As discussed 
later, these surface molecules play an important role in the initiation of TCR signaling.  
The expression of CD4 or CD8 is on a T cell’s surface is determined by the class of MHC 
recognized by its TCR.   Double positive thyomcytes that recognize peptide in the 
context of MHC class I develop into CD8
+
 single positive T cells.  These cells, also 
known as CTLs (cytotoxic T lymphocytes), primarily serve to induce cell death in cells 
displaying  non-self antigen on their surface MHC class I (Hogquist et al., 1993).  By 
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surveying peptides produced within a given cell CTLs provide protection against viruses 
(Long and Jacobson, 1989; Morrison et al., 1986; Zinkernagel and Doherty, 1979) and 
also form an important part of the immune system’s response to cancer (Garcia-Lora et 
al., 2003; Seliger et al., 2006).                             
Thymocytes recognizing peptide in the context of MHC class II molecules 
develop into CD4
+
 single positive cells (Klein et al., 2009; Kraj et al., 2001; MacDonald 
et al., 1988; Starr et al., 2003).  CD4
+
 T cells (T helper cells) are integral to the ability of 
the adaptive immune system to deploy pathogen-appropriate responses.  T helper cells 
serve to process signals present at the time of their activation and respond by initiating 
one of several programs of cytokine production that serves to drive the immune system’s 
response to a given pathogen type (Abbas et al., 1996).  At the completion of thymic 
education, a T cell is an MHC class-restricted naïve cell capable of responding to its 
cognate antigen. 
 
NKT cells: Lipid reactive T cells 
While most T cells react only with peptide antigens presented by MHC 
molecules, an important exception does exist. A small subset of thymus-derived 
lymphocytes recognize lipid antigens in the context of the CD1d molecule in mice, or any 
of the CD1 family in humans (Brossay et al., 1998; Kawano et al., 1998; Tsuji, 2006).  
These cells are termed natural killer T cells (NKT cells) due to the presence of NK cell 
surface markers alongside a TCR in many subsets.   The largest NKT cell subset is 
characterized by a semi-invariant αβ TCR and is termed iNKT (invariant NKT) cells.  
Other populations of NKT cells have diverse αβ or γδ TCRs,  but all are CD1-restricted 
(Godfrey et al., 2004; Van Kaer, 2007; Van Kaer and Joyce, 2005).  As with αβ T cells, 
NKT cells undergo positive and negative selection (D’Cruz et al., 2010; Hu et al., 2011).  
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NKT cells can be activated by bacterial-derived glycolipids and are important 
early responders to many pathogens such as Mycobacterium tuberculosis, various species 
of Leishmania, and other pathogenic microorganisms (Brigl et al., 2003; Cohen et al., 
2009; Ishikawa et al., 2000; Moody et al., 2004; Wiethe et al., 2008).  Activation of NKT 
cells via exogenous lipids such as α-GalCer can modulate immune responses to tumors 
(Kawano et al., 1997, 1998; Motohashi et al., 2011; Vivier et al., 2012) or serve to 
enhance vaccines (Cerundolo et al., 2009; Joyce et al., 2011; Padte et al., 2011).  While 
NKT cell cells are a relatively small population of lymphocytes (Van Kaer, 2007), they 
occupy an important niche between innate and adaptive immunity  and can provide an 
early release of cytokines that contributes to shaping a developing immune response 
(Ishikawa et al., 2000; Stanley et al., 2008).               
         
T helper subsets: General 
   In order to respond to different types of pathogens, CD4
+
 T cells are able to 
differentiate into several different effector types after being activated through their TCR.  
Each effector type (also called lineage or subset) produces a set of hallmark cytokines, 
while inhibiting the transcription of genes associated with other effector sets (Grogan et 
al., 2001).  Each subset also expresses different patterns of chemokine receptors 
(Breitfeld et al., 2000; Campbell et al., 2003; Kim, 2005; Schaerli et al., 2000), meaning 
that different subsets will migrate to a site in response to different stimuli.  The effector 
programming that a T helper cell adopts is, in large part, determined by the local cytokine 
milieu at the time of activation.  Cytokine signaling drives the expression of lineage-
specific transcription factors sometimes referred to as master regulators (Kanhere et al., 
2012; Nakayama and Yamashita, 2008; Vahedi et al., 2013).  The combined signals from 
the TCR and cytokine receptors, along with the activity of the master regulators, drive the 
lineage-specific cytokine expression which characterizes the T helper subsets (Corn et al., 
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2005; Kaplan et al., 1996a; Nakayama and Yamashita, 2010; Rooney et al., 1994; Zhang 
and Boothby, 2006; Zhu and Paul, 2010).  
The two best studied effector programs are the T helper 1 (Th1) and T helper 2 (Th2) 
responses (Mosmann et al., 1986) (Fig. 1.1).   Th1 cells express the master regulator T-
bet and produce IFN-γ.  IFN-γ is a type II interferon which activates macrophages to 
promote the clearance of intracellular pathogens such as Listeria monocytogenes (Hsieh 
et al., 1993) and Mycobacterium tuberculosis (Barnes et al., 1993; Cooper et al., 1993; 
Orme et al., 1993).  IFN-γ also triggers B cells to class switch to the IgG2a isotype.  The 
constant regions of IgG2a antibodies interact with receptors on phagocytes leading to 
increased uptake of antigens bound to the variable region of the antibody (Bolland, 2005; 
Cohen-Solal et al., 2004; Kimberly et al., 1989; Nimmerjahn et al., 2005).  This antibody-
mediated phagocytosis mechanism is termed opsonization (Mudd et al., 1929; Noguchi, 
1907), and further enhances the effectiveness of phagocytes in a Th1 response (Cohen et 
al., 2011; Oishi et al., 2013; Schlageter and Kozel, 1990).    By inducing the production 
of IgG2a and activating macrophages, the IFN-γ produced by Th1 effectors guides the 
immune response of cells from both the innate and adaptive arms of the immune to clear 
pathogens.    
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Figure 1.1.  Th1 and Th2 development following antigen stimulation. After activation 
via the T cell receptor, cytokines in the local environment steer commitment to one of 
several mutually exclusive effector lineages.  Shown above are two best studied effector 
programs: Th1 and Th2.     
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The importance of the Th1 response and IFN-γ in human health can be seen in 
patients lacking a functional IFN-γ receptor.  These patients are highly susceptible to 
mycobacterial infections and other intracellular bacteria (Arend et al., 2001; Dorman et 
al., 2004; Jouanguy et al., 1996; Pierre-Audigier et al., 1997; Roesler et al., 1999; Vinh et 
al., 2009).  Th1 effectors have also been found to play a major role in the pathology of 
autoimmune diseases such as type I diabetes (Haskins and Cooke, 2011; Katz et al., 
1995; Öling et al., 2012; Trembleau et al., 1995).  The Th1 subset is therefore a very 
important but potentially very destructive lineage.         
The Th2 effector program (Fig. 1.1) is characterized by expression of the master 
regulator GATA3 (Pai et al., 2004; Ranganath et al., 1998; Zhang et al., 1997a; Zheng 
and Flavell, 1997) and production of IL-3, IL-4, and IL-13 (Abbas et al., 1996; Heinzel, 
1989).  Th2 effectors direct immune responses against helminthic parasites (Finkelman et 
al., 2004; Panzer et al., 2012; Svetic et al., 1993).  The humoral aspect of a Th2 response 
is characterized by the class switching of B cells to IgG1 and IgE (Liu et al., 2003; 
Matsumoto et al., 2013; Snapper and Paul, 1987), while the cell mediated effects stem 
from the recruitment of eosinophils and mast cells to the site of inflammation (Hagan et 
al., 1985; Hepworth et al., 2012; Masure et al., 2013; Shintoku et al., 2013).  IL-4 
produced by Th2s also provides anti-apoptotic and proliferative signals to B cells 
(Howard and Paul, 1983; Liao et al., 2011a; Swain and Dutton, 1985), and many other 
cell types (Crosby and Waters, 2010; Hallett et al., 2012). The IgE produced under Th2 
conditions binds and cross-links Fc receptors on the surface of mast cells, which triggers 
release of histamines and cytokines (Ishizaka et al., 1972; König and Ishizaka, 1974; 
König et al., 1974).  Protection from helminthes has been important throughout 
evolutionary history of mammals (Ilic et al., 2012; Maizels et al., 2009; Pillai and Bix, 
2011; Pulendran and Artis, 2012), but in the developed world, the Th2 response is most 
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commonly seen in atopic diseases such as allergic asthma (Holgate, 2012; Romagnani, 
1994; Wambre et al., 2012).                     
Beyond Th1 and Th2 effector programs, several other CD4
+
 T cell subsets have 
been identified.  As with Th1 and Th2 lineages, each of the other T helper types regulates 
distinct processes in the immune system.  The Th17 subset produces IL-17, which serves 
to recruit neutrophils to clear extracellular bacterial and fungal infections (Drewniak et 
al., 2013; Hernández-Santos et al., 2012; Higgins et al., 2006; Puel et al., 2011).  
Development from a naïve CD4
+
 T cell to a Th17 effector is mediated by TGF-β and IL-6 
signaling and the master regulator RORγt (Harrington et al., 2006; Ivanov et al., 2006; 
Weaver et al., 2006).  Th17 polarization is opposed by signaling from IL-4, IL-12, IL-2, 
and IFN-γ (Zhu and Paul, 2010).  The Th17 effector program also has an etiologic role in 
the autoimmune diseases multiple sclerosis (Maddur et al., 2012; Saresella et al., 2013; 
Wang et al., 2013), psoriasis (Cauli and Mathieu, 2012; Chiu et al., 2012), and 
rheumatoid arthritis (Komatsu and Takayanagi, 2012; Maddur et al., 2012; Miossec and 
Kolls, 2012).  Th17 cells demonstrate some flexibility in cytokine expression, as fully 
differentiated cells can be made to produce IFN-γ under physiological conditions while 
maintaining production of IL-17 (Basu et al., 2013; Lexberg et al., 2010; Mukasa et al., 
2010).          
The T follicular helper subset (TFH) secretes IL-21(Schaerli et al., 2000) and 
specializes in the formation and maintenance of germinal centers (Breitfeld et al., 2000; 
Kim et al., 2001; Schaerli et al., 2000).   Development along the TFH program in humans 
requires IL-12 signaling (Schmitt et al., 2009),  the expression of Bcl6 and the repression 
of Blimp-1 (Johnston et al., 2009; Yu et al., 2009).  In mice, Bcl6 expression, along with 
IL-21, IL-6, and STAT3 signaling drive TFH development (Nurieva et al., 2008).  In both 
humans and mice the inducible costimulator ICOS is required for effective TFH 
polarization (Bauquet et al., 2008; Breitfeld et al., 2000).  TFH effectors can express the 
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master regulators and cytokines associated with one of the other effector subsets: i.e. in a 
Th1 dominated response, TFH cells can express T-bet and produce Ifng (Crotty, 2011; 
Johnston et al., 2009), whereas in a Th2 response they would express GATA3 and 
produce Th2 cytokines (King and Mohrs, 2009; Reinhardt et al., 2009; Yusuf et al., 
2010).  While TFH cells play an important role in generating effective humoral responses 
against antigens, they are also implicated in autoimmune disorders, especially in those 
characterized by autoreactive antibodies such as systemic lupus erythematosus (SLE) and 
rheumatoid arthritis (King et al., 2008; Vinuesa et al., 2005). 
Functionally distinct from the T helper lineages are the CD4
+
 regulatory T cells 
(Tregs).  Tregs are divided into two categories based on how the regulatory function was 
acquired.  Tregs which develop from the recognition of self-antigens in the thymus are 
termed thymic Tregs (tTreg) or natural Tregs (nTregs) (Aschenbrenner et al., 2007; 
Kawahata et al., 2002; Olivares-Villagómez et al., 1998).  T cells acquiring regulatory 
function after exiting the thymus are termed induced Tregs (iTregs) (Apostolou et al., 
2002; Josefowicz et al., 2012).  Regulatory T cells have the ability to suppress the 
effector responses of other T cells, both by the secretion of IL-10 and TGF-β, and by 
contact dependent inhibitory mechanisms (Kumar et al., 1997).  The transcription factor 
Foxp3 is the master regulator of the Treg program (Fontenot et al., 2003), and in cases 
where  humans or mice lack functional Foxp3, widespread autoimmunity develops 
(Bennett et al., 2001; Josefowicz et al., 2012; Wildin et al., 2001).  The ability to generate 
and maintain a functional population of regulatory T cells has repeatedly been shown to 
be vital for the prevention of autoimmunity.    
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T cell activation: TCR signaling 
 CD4
+
 T cells exit the thymus capable of adopting any one of several effector or 
regulatory functions.  In this naïve state, the cells do not produce cytokines or provide 
help to other cells of the immune system.  For a helper T cell to transition from naïve to 
an effector, it must experience its cognate antigen in the context of an antigen presenting 
cell’s expressed MHC class II.  TCR signaling regulates proliferation, survival, and the 
effector function of a T cell (Lanzavecchia et al., 1999).  To carry this out, the receptor 
complex is able to invoke multiple signaling pathways and exert control over a host of 
genes.       
 The α and β chains of the T cell receptor lack signaling components, and instead 
rely on other components of the receptor complex for signal transduction.  The signaling 
components of the TCR are the invariant CD3 proteins and the TCRζ chain (sometimes 
called CD3ζ). The CD3 complex is composed of multiple subunits: CD3δ, CD3ε, and 
CD3γ. These three subunits form into two heterodimers, and, together with a TCRζ 
homodimer form the signaling component of the TCR (Guy and Vignali, 2009; Shores 
and Love, 1997; Zehn et al., 2012).   Each invariant chain of the TCR contains one or 
more ITAM (immunoreceptor tyrosine-based activation motif) domains.  The ITAMs 
become phosphorylated during the course of TCR stimulation, and this phosphorylation 
allows for the recruitment and activation of multiple downstream effector proteins and 
adaptors during TCR stimulation (Guy and Vignali, 2009; Humphrey et al., 2005; 
Salmond et al., 2009; Au-Yeung et al., 2009; Zhang et al., 1998b).          
After the αβ dimer binds to its cognate antigen in the context of MHC, either the 
CD4
 
or the CD8 coreceptor binds to the MHC molecule, drawing its cytoplasmic domain 
into closer proximity to ITAMS of the CD3 and TCRζ complex (Leitenberg et al., 1998; 
Veillette et al., 1988, 1989).  Associated with the cytoplasmic tail of the coreceptor (CD4 
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or CD8) is the Src family kinase Lck. Together with the Src family kinase  Fyn, Lck then 
phosphorylates the ITAMs of the CD3  and TCRζ dimers (Guy and Vignali, 2009; 
Palacios and Weiss, 2004). The phosphorylation of TCRζ allows for the recruitment and 
phosphorylation of the Syk-family tyrosine kinase ZAP-70 (Salmond et al., 2009; Au-
Yeung et al., 2009).  Phosphorylated ZAP-70 interacts with phospholipase Cγ1 (PLCγ1), 
which is activated by the Tec kinase Itk (Berg et al., 2005; Liu et al., 1998b; Park et al., 
1991; Reynolds et al., 2002; Shan and Wange, 1999; Smith-Garvin et al., 2009).  PLCγ1 
cleaves the membrane phospholipid PI(4,5)P2  to produce inositol 1,4,5 triphosphate (IP3) 
and diacylglycerol (DAG) (Choi et al., 2007; Patterson et al., 2005).  Each of these 
molecules activates a separate set of signaling pathways.    
IP3 binds to receptors on the endoplasmic reticulum which triggers a release of 
calcium into the cytoplasm (Berridge, 2009; Berridge and Patel, 1968; Prentki et al., 
1985; Streb et al., 1983, 1984; Williamson et al., 1985).  This Ca
++
 ion flux leads to the 
activation of the phosphatase calcineurin, which dephosphorylates members of the NFAT 
(nuclear factor of activated T cells) family of transcription factors (Loh et al., 1996; Luo 
et al., 1996; Park et al., 1995). Once dephosphorylated, these transcription factors migrate 
to the nucleus and transactivate multiple target genes (Hogan et al., 2003; Kiani et al., 
2001; Macian, 2005; Rooney et al., 1994).  NFAT signaling is required for the function 
of several T helper subsets (Agarwal et al., 2000; Kiani et al., 2001; Porter and Clipstone, 
2002; Rooney et al., 1994), and is required for the proliferation of activated effector 
CD4
+
 T cells and the production of IL-2 (Jain et al., 1993; McCaffrey et al., 1993; Novak 
et al., 1990; Shaw et al., 1988).     
 The DAG produced by PLCγ1 binds to and activates a member of the protein 
kinase C (PKC) family of kinases, PKCθ (Altman and Villalba, 2002, 2003; Baier et al., 
1993).  The activation of PKCθ leads to the activation of members of the NF-κB family 
of transcription factors (Altman and Villalba, 2002; Coudronniere et al., 2000).  The   
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NF-κB family of transcription factors is involved in the regulation of many genes in 
lymphocytes and can be activated by multiple receptors including the TCR (Baldwin, 
2012; Karin and Ben-Neriah, 2000; Oh and Ghosh, 2013; Ruan and Chen, 2012; 
Vallabhapurapu and Karin, 2009; Visekruna et al., 2012).  These transcription factors are 
characterized by an N-terminal Rel homology domain (RHD) required for dimerization 
and site-specific DNA binding, and each dimer has either a transactivating or 
transrepressing domain at the C- terminus (Hoffmann et al., 2006; Vallabhapurapu and 
Karin, 2009).  The NF-κB family members NF-κB1 (p50/p105) and NF-κB2 (p52/p100) 
are found in an inactive precursor state (p105 and p100) and are processed by the 
proteasome into their active forms (p50 and p52) (Blank et al., 1991; Fan and Maniatis, 
1991; Mercurio et al., 1992; Neri et al., 1991; Sen and Baltimore, 1986).  A second set of 
NF-κB transcription factors is composed of RelA (p65) (Baeuerle and Baltimore, 1989; 
Urban and Baeuerle, 1991), RelB (Ryseck et al., 1992), and c-Rel (Brownell et al., 1987; 
Kieran et al., 1990; Sica et al., 1992).  NF-κB transcription factors function as either 
homodimers or heterodimers (Oeckinghaus and Ghosh, 2009; Rattner et al., 1991; Urban 
et al., 1991).  These proteins are kept inactive via interactions with inhibitory factors 
termed IκBs (inhibitors of  NF-κB), which prevent nuclear translocation of dimerized 
NF-κBs (Baeuerle and Baltimore, 1988; Davis et al., 1991; Ganchi et al., 1992; Inoue et 
al., 1992; Vallabhapurapu and Karin, 2009).  During activation, IKK (IκB kinase) 
complexes phosphorlate IκBs, leading to the release and nuclear localization of NF-κB 
dimers (Rothwarf et al., 1998; Zandi et al., 1997, 1998). 
  In the case of signaling from the TCR, PKCθ is able to phosphorylate the CARD 
(caspase recruitment domain) domain protein Carma1 (Blonska and Lin, 2009, 2011; Lin 
and Wang, 2004; Matsumoto et al., 2005; Sommer et al., 2005; Wang et al., 2004).  The 
phosphorylation of Carma1 allows for its binding to Bcl10 and Malt1 at the plasma 
membrane (Cheng et al., 2011; Hara et al., 2004; Shinohara et al., 2007; Wang et al., 
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2004).  This protein complex, sometimes called the CBM complex, is essential for the 
ubiquitination of IKKγ (also known as NEMO) (Li et al., 2001; Poyet et al., 2000; 
Yamaoka et al., 1998).  The ubiquitination of NEMO and PKCθ-mediated 
phosphorylation activates the IKK complex (Blonska and Lin, 2011; Lee et al., 1998; 
Ling et al., 1998).  Activated IKK complexes phosphorylate IκB proteins, leading to their 
disassociation from NF-κB dimers, allowing the NF-κB dimers to translocate to the 
nucleus and regulate the transcription of multiple genes (Ganchi et al., 1992; Zandi et al., 
1998).   
 The TCR signals through multiple pathways, each of which controls multiple 
genes.  Signaling through the TCR provides signals that are necessary for T cell survival, 
proliferation, and differentiation.  Stimulation of the TCR alone will not, however allow 
for a functional immune response.  Another set of signaling pathways must be activated 
to achieve T cell activation.          
 
T cell activation: Costimulators and co-repressors  
 Early studies in TCR signaling found that stimulation of the TCR was insufficient 
to induce proliferation (Green et al., 1994; Jenkins and Schwartz, 1987; Quill and 
Schwartz, 1987; Smith et al., 1997).  It was found that when T cells were stimulated 
solely via the TCR, clonal anergy or cell death would occur (Bartik et al., 1994; Boise et 
al., 1995; Koulova et al., 1991; Linsley et al., 1990; Watts, 2010). This led to the 
hypothesis that a second signal was needed to successfully activate lymphocytes 
(Bretscher and Cohn, 1970; Jenkins and Schwartz, 1987; Lafferty and Woolnough, 1977; 
Quill and Schwartz, 1987).  The requirement for a second signal  provides some 
safeguard against inappropriate immune responses such as autoimmunity as well as 
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modulating and enhancing signaling through the TCR (Boise et al., 1995; Chambers, 
2001; Lafferty and Gill, 1993; Lenschow et al., 1996).    
The second, or costimulatory, signal is typically generated by membrane bound 
receptors on the T cell interacting with ligands on antigen presenting cells. The 
membrane-bound costimulator CD28 is the main source of this second signal during T 
cell activation (Boise et al., 1995; June et al., 1987; Lesslauer et al., 1986).  CD28 is a 
homo-dimeric Ig-superfamily member protein that binds to B7 molecules expressed on 
antigen presenting cells (Koulova et al., 1991; Linsley et al., 1990, 1991).  Upon the 
interaction of CD28 with B7, the YMNM motif of the intracellular domain of CD28 is 
tyrosine phosphorylated via Lck and Fyn (Bjørgo and Taskén, 2010; Lenschow et al., 
1996; Raab et al., 1995; Rudd et al., 2009; Salmond et al., 2009).  PI3K and Grb2 then 
bind to CD28 via SH3 domain interactions (Okkenhaug and Rottapel, 1998).   
PI3K produces PIP3, which binds to PDK1 via the pleckstrin homology (PH) 
domain (Bayascas, 2011).  PDK1 phosphorylates Akt on T308, resulting in partial 
activation (Fayard et al., 2011; Parry et al., 1997; Rudd et al., 2009).   Signaling from 
CD28 via Akt leads to mammalian target of rapamycin (mTOR)-aided translation (Wu et 
al., 2005), activation of cyclin-dependent kinases (Appleman et al., 2000; Boonen et al., 
1999; Rowell et al., 2005), and the inhibition of FAS-induced apoptotic signaling (Jones 
et al., 2002).    
 The activation induced binding of Grb2 to CD28 facilitates the recruitment of 
guanine exchange factors (GEFs) such as Vav1 and SOS (Son of Sevenless) (Buday et 
al., 1994; Gogishvili et al., 2008; Schneider and Rudd, 2008; Schneider et al., 1995) to 
CD28.  These GEFs activate small GTPases such as Rac1 and p21
ras
.  These GTPases 
activate the JNK and MAPK kinase cascades, leading to the activation of AP-1 
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transcription factors and the transcription of genes such as IL-2 (Izquierdo et al., 1993; 
Schneider and Rudd, 2008; Schneider et al., 1995; Su et al., 1994).        
  The overall effect of CD28 signaling is to promote survival and proliferation 
during T cell activation (Boise et al., 1995; Linsley et al., 1991; Noel et al., 1996a; Rudd 
et al., 2009).  This is accomplished via up-regulating the expression of Bcl-XL (Boise et 
al., 1995; Wu et al., 2005), increasing the production of IL-2 (Chen et al., 1998; Jenkins 
et al., 1991; June et al., 1987; Linsley et al., 1991), promoting the activity of cyclin-
dependent kinases (Appleman et al., 2000; Boonen et al., 1999; Rowell et al., 2005), and 
the alteration of cell energetics to accommodate increased energy requirements of 
activation (Frauwirth et al., 2002; Jacobs et al., 2008; Marko et al., 2010).  The signaling 
pathways engaged by CD28 synergize with those initiated by the TCR to enable a 
functional T cell response by promoting clonal expansion and preventing apoptosis.      
 A second important costimulatory molecule in the B7 receptor family is inducible 
co-stimulatory molecule (ICOS) (Hutloff et al., 1999; Rudd and Schneider, 2003; 
Yoshinaga et al., 1999).  As its name suggests, ICOS is only faintly expressed in naïve T 
cells, but its expression is induced during TCR/CD28-mediate activation (McAdam et al., 
2000; Simpson et al., 2010).  ICOS is activated by ligation with B7RP-1, which is 
expressed on antigen presenting cells (Yoshinaga et al., 1999).  Stimulation via ICOS 
promotes survival and proliferations, but does not induce IL-2 (Hutloff et al., 1999).  
ICOS signaling can promote development along several different T lineages, and is 
especially important in the development of TFH cells, with ICOS deficiency resulting in 
impaired germinal center formation and an absence of TFH memory cells (Crotty, 2011; 
Simpson et al., 2010).  Signaling through ICOS provides pro-survival and proliferative 
signals through pathways downstream of AKT (Rudd and Schneider, 2003; Simpson et 
al., 2010) and also modulates the effector responses of multiple T lineages by increasing 
cytokine secretion or providing tolerogenic signals (Bauquet et al., 2008; Gao et al., 
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2012; Simpson et al., 2010).  By of regulating and increasing T helper responses, 
promoting cell survival, and promoting the TFH lineage, ICOS serves as a key co-
stimulatory molecule in CD4
+
 T cell activation and development.     
 In the same family as ICOS and CD28 but possessing significantly different 
functionality is cytotoxic T lymphocyte antigen 4 (CTLA-4).  Like ICOS, CTLA-4 is 
upregulated after T cell activation (Alegre et al., 1996; Freeman et al., 1992; Sansom, 
2000).  However, CTLA-4 signaling is antagonistic towards signals from TCR/CD3 and 
CD28 (Noel et al., 1996b; Walunas et al., 1994, 1996).  While the exact mechanisms of 
signal-dampening by CTLA-4 are unclear, and several mechanisms have been proposed 
(Bour-Jordan et al., 2011; Noel et al., 1996b; Rudd and Schneider, 2003; Rudd et al., 
2009).  There is evidence to support competition for PI3K, dephosphorylation of CD3 
and CD28 complexes via PP2a, and disruption of cytoskeletal architecture at the immune 
synapse as likely mechanisms of CTLA-4 function (Bour-Jordan et al., 2011; Greenwald 
et al., 2002; Rudd and Schneider, 2003; Rudd et al., 2009; Scalapino and Daikh, 2008).       
While the mechanisms underpinning CTLA-4’s function remain unclear, the 
importance of its function has been demonstrated in a knockout mouse model.  Mice 
deficient in CTLA-4 suffer from severe lymphoproliferative disorders as well as 
autoimmunity and fall fatally ill at a young age (Krummel and Allison, 1995; Tivol et al., 
1995; Waterhouse et al., 1995).  CTLA-4 plays a crucial role in tolerance and immune 
regulation by raising the signaling threshold of the TCR complex and CD28.  Without 
this dampening effect, lower levels of TCR/CD28 stimulation would be sufficient to 
drive strong immune responses.      
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Differentiation of naïve CD4
+
 cells into effector subsets: Cytokine signaling 
While the T cell receptor complex and costimulators are required for activation, a 
substantial portion of the signaling input that controls differentiation and survival after 
stimulation comes from cytokines.  Cytokines bind to membrane-bound receptors on their 
target cell.  The cytokine receptor is then able to initiate signaling through multiple 
pathways, and can influence proliferation (Liao et al., 2011a; Yoo et al., 2002), survival, 
and acquisition of effector function (Bradley et al., 1995; Hsieh et al., 1993; Liao et al., 
2011b; Manetti et al., 1993).  Cytokine receptors are dimeric membrane spanning 
proteins that are expressed in many immune and non-immune cell types.   
One pathway common among many  cytokine receptors is the JAK-STAT 
pathway (Shuai and Liu, 2003).  The cytoplasmic tails of cytokine receptors are 
associated with tyrosine kinases called Janus kinases (JAKs) (Murray, 2007; Watling et 
al., 1993; Wilks et al., 1991).   Upon receptor-ligand interaction, JAKs phosphorylate 
tyrosines on the cytoplasmic domains of the receptor subunits(Beadling et al., 1994; Silva 
et al., 1994; Silvennoinen et al., 1993).  These phosphotyrosines allow STAT molecules 
to bind to the receptor via SH2 domains and undergo tyrosine phosphorylation (Jacobson 
et al., 1995; Shuai et al., 1993; Silva et al., 1994).  This phosphorylation allows for STAT 
molecules to form homo- and hetero-dimers, translocate to the nucleus, bind specific 
DNA elements, and facilitate transcription of target genes (Jacobson et al., 1995; Li et al., 
1996; Murray, 2007; Shuai et al., 1994).  While the activation of STAT proteins is an 
important function, JAKs are also involved in other signal transduction pathways such as 
the PI3K/AKT pathway (Sharfe et al., 1995).  The importance of JAK3 in particular can 
be seen in humans or mice lacking a functional gene produce.  The absence of functional 
JAK3 results in severe combined immune deficiency (SCID) due to defective signal 
transduction from IL-2 and IL-7 (Macchi et al., 1995; Russell et al., 1995).        
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One set of genes upregulated by STATs are the master regulator transcription 
factors (Afkarian et al., 2002; Kurata et al., 1999; Onodera et al., 2010).  The early 
activation of STAT proteins has been shown to be an important first step in the initiation 
of effector programming.  The combined actions of the master regulator transcription 
factors and signaling through the TCR and cytokine receptors enhances the transcription 
of genes associated with one subset and represses genes from other effector programs. 
 
Cytokine signaling: Th1 development 
Development into a Th1 effector (Fig. 1.2B) is dependent upon signaling from IL-
12 via its receptor (Carl et al., 1993; Jacobson et al., 1995; Manetti et al., 1993; Presky et 
al., 1996). Interestingly, expression of the IL-12rβ subunit is induced by  signaling from 
CD28, IFN-γ and IL-2 during T cell activation, and can be blocked by IL-4 signaling 
(Afkarian et al., 2002; Elloso and Scott, 2001; Rogge et al., 1997; Szabo et al., 1995, 
1997; Wu et al., 1997) The IL-12 receptor is capable of signaling both in a STAT-
dependent and STAT-independent manner (Lund et al., 2004) (Fig. 1.3).  Upon IL-12 
binding, JAK2 and TYK2 associated with IL-12 receptor phosphorylates tyrosines on the 
cytoplasmic tail of the IL-12rβ chain, allowing for the recruitment and activation of 
STAT4 (Bacon et al., 1995a, 1995b; Jacobson et al., 1995).  Phosphorylated STAT4 
dimerizes, translocates to the nucleus, and drives the transcription of Ifng (Morinobu et 
al., 2002; Nishikomori et al., 2002; Zhang and Boothby, 2006). STAT4 also enhances 
and maintains the expression of T-bet (White et al., 2001).  While many effects of IL-12 
signaling are mediated by STAT4, there are other pathways invoked by the IL-12 
receptor (Fig. 1.3). 
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Figure 1.2  Master regulators and STATs drive T helper polarization.  Shown are the 
STATs and master regulators downstream of polarizing cytokine for Th1 and Th2 
development (A).  The interplay of different signaling pathways is shown for Th1(B) and 
Th2 (C) development.    
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Figure 1.3 IL-12 signaling by STAT4-dependent and independent mechanisms.      
IL-12 binding to its receptor induces Ifng expression via STAT4-dependent and                 
STAT4-independent mechanisms.  Gene names are in italics.   
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The IL-12 receptor also signals through p38 MAPK (Lu et al., 1999; Rincón et al., 
1998) and the PI3K/Akt pathway (Rao et al., 2010; Yoo et al., 2002).  Akt phosphorylates 
the forkhead transcription factor FOXO1.  This phosphorylation inactivates FOXO1 and 
leads to its translocation to the cytoplasm (Brunet et al., 1999; Guo et al., 1999; Rena et 
al., 1999).   The inactivation of FOXO1 leads to an increased expression of T-bet (Rao et 
al., 2012) as well as possibly enhancing the transcription of Ifng (Ouyang et al., 2012).  
T-bet, as well as being required for Ifng transcription (Szabo et al., 2000, 2002) also 
inhibits the transcription of the Th2 master regulator GATA3 (Usui et al., 2006), 
preserving Th1 lineage commitment and function (Ferber et al., 1999).  These  STAT4- 
independent signals also account for proliferative effects of IL-12 (Morinobu et al., 2002)   
Other cytokine important for developing Th1 cells include IL-2 and IFN-γ.  IFN-γ 
signaling via its membrane-bound receptor activates STAT1.  Active STAT1 drives the 
expression of T-bet, which is essential for IFN-γ production and IL-12rβ expression 
(Afkarian et al., 2002; Szabo et al., 2000).  IL-2, aside from its proliferative and anti-
apoptotic effects (Bödeker et al., 1980; Ma et al., 2006), has also been shown to be 
essential for efficient transcription of Ifng via activation of STAT5 (Shi et al., 2008).  
Development along the Th1 lineage is opposed by Th2 conditions, and exposure to IL-4 
can prevent the transduction of Th1 polarizing signals via repression of Il12rβ 
transcription (Afkarian et al., 2002; Ferber et al., 1999; Szabo et al., 1995). 
 
Cytokine signaling: Th2 development 
Th2 polarization (Fig. 1.2C) is driven by IL-4 signaling through the IL-4 receptor 
(IL-4R).  The IL-4 receptor signals through multiple pathways to regulate gene 
expression in CD4
+
 T cells.  Activation of STAT6 by IL-4 receptor-associated JAKs is 
one of the primary pathways by which IL-4 can exert transcriptional control (Hou et al., 
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1994; Kaplan et al., 1996a; Kuperman et al., 1998).  STAT6 up-regulates the expression 
of the Th2 master regulator GATA3 (Kaplan et al., 1996a; Kurata et al., 1999; Onodera et 
al., 2010; Ranganath et al., 1998; Zheng and Flavell, 1997).  GATA3 and STAT6 then 
enhance the transcription of Th2 cytokines (Kaplan et al., 1996a; Ranganath et al., 1998; 
Zheng and Flavell, 1997).  GATA3 also represses the expression of T-bet, the IL-12 
receptor, and interferon gamma (Ferber et al., 1999; Nakayama and Yamashita, 2008; 
Ouyang et al., 1998; Usui et al., 2003).   
Unlike the IL-12 receptor, the IL-4 receptor is expressed before TCR stimulation 
(Kupper et al., 1987; Lowenthal et al., 1988), allowing IL-4 signaling to preempt other 
effector programs.  Foundational work found that a mouse strain-specific susceptibility to 
Leishmania infection was due to a surge in IL-4 production in the first 16 hours post 
infection (Launois et al., 1995).  This initial IL-4 inhibited the signaling of IL-12 and the 
development of a Th1 response (Aseffa et al., 2002; Carl et al., 1993; Himmelrich et al., 
2000).  In human health, it has been hypothesized that Treg and Th2 responses to 
helminthic pathogens could inhibit a prophylactic immune response against 
Mycobacterium tuberculosis as these pathogens have a relatively high rate of co-infection 
but require different opposed immune responses for clearance (Elias et al., 2006; Ezenwa 
et al., 2010; Rafi et al., 2012; Resende Co et al., 2007).  The dominance of the Th2 
response over the more essential Th1 response may sometimes pose a significant 
challenge in the clearance of certain pathogens in the context of a helminth infection.   
 
T cell activation and differentiation 
While cytokine signaling plays a central role in directing T helper fate decisions, 
variables in TCR stimulation and costimulation can significantly impact the adoption of 
an effector program.  While the TCR and costimulatory molecules signal mainly through 
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subset-independent factors, subtle differences in the relative strength of these signals can 
skew a CD4
+
 T cell towards development into one subset or another.  One demonstration 
of this phenomenon is found in studies using altered peptide ligands.  Depending on the 
exact peptide, altered peptide ligands can induce anergy or lead to different effector 
programs being adopted under the same stimulation conditions (Constant and Bottomly, 
1997; Nicholson et al., 1995; Windhagen et al., 1995).  Specifically, altered ligands that 
demonstrated increased affinity for the TCR generated a much higher proportion of IFN-γ 
producing cells than lower affinity ligands (Kumar et al., 1995; Murray et al., 1989; 
Windhagen et al., 1995)  The use of lower affinity altered ligands has been shown to lead 
to lower levels of tyrosine phosphorylation on TCRζ and ZAP-70, as well as a different 
pattern of activation-induced calcium flux (Boutin et al., 1997).  The sustained increase 
of cytosolic calcium  induced by the agonist peptide allowed for development along the 
Th1 lineage, while the brief calcium concentration increase brought on by the low-
affinity altered peptide ligand was sufficient for Th2, but not Th1, development (Boutin 
et al., 1997).  This demonstrates that the affinity of an antigen for the TCR can alter the 
pathways by which the TCR complex signals, and thus, can skew cells towards one 
effector program over another.     
The binding of any ligand to a receptor is controlled not only by the affinity of the 
receptor, but also the concentration of the ligand relative to the receptor.  Just as altering 
the affinity peptide-TCR binding can modulate the strength of TCR signaling, so too can 
altering the concentration of antigen (Constant and Bottomly, 1997; Parish and Liew, 
1972).  The effects of antigen concentration on T helper cell differentiation are in part 
dictated by the type of antigen used (Constant and Bottomly, 1997).  Soluble protein 
antigens have been shown to exhibit different properties than attenuated or killed 
parasites such as Trichuris muris (Bancroft et al., 1994) or Leishmania major (Bretscher 
et al., 1992).  Parasites generally evoke a Th1 response when administered in a low dose 
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and a Th2 response when given in a high dose.  Conversely, a low dose of protein antigen 
will typically cause a Th2 response, whereas a higher dose will create a Th1 response 
(Constant and Bottomly, 1997).  A very high dose of protein antigen will however 
generate a Th2 response (Hosken et al., 1995).   This discrepancy may be due to the fact 
that post-translational modifications of peptides derived from bacteria or other pathogens 
can greatly increase APC uptake and antigen display (Sallusto et al., 1995). Therefore, 
higher doses of a whole pathogen may lead to overstimulation and death of Th1, but not 
Th2 effectors (Ramsdell et al., 1994; Zhang et al., 1997b).  The fact that higher 
concentrations of soluble protein antigens evoke a Th2 response may also be due in part 
to the greater resistance of Th2 cells to activation-induced cell death (Constant and 
Bottomly, 1997; Zhang et al., 1997b). 
                       
Epigenetics and transcription in cytokine genes 
Every nucleated somatic cell contains its entire genome.  For cells that have 
begun to differentiate, this entails that large portions of the genome contain genes no 
longer relevant to the cells function or development.  Conversely, genes that were 
unnecessary in progenitor stages may become necessary as the cell progressively makes 
fate decisions.  Much as a bookstore will have the books most in demand at the front of 
the store and less popular items pushed to the back, so too are genes necessary for a cells 
function kept accessible to transcriptional machinery while genes associated with other 
cell fates are rendered  inaccessible.       
DNA in the eukaryotic nucleus is in the form of chromatin (Levene, 1903).  At its 
most basic, chromatin is a double-stranded DNA molecule wound around histone 
octomers.  Between 145  and 147 nucleotides are wrapped around each histone in a           
super-helical turn followed by up to eighty base pairs of DNA until the next histone 
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octomer (Crick, 1976; Fuller, 1971; Luger and Richmond, 1998; Luger et al., 2012).  
Chromatin is classified in two broad categories: euchromatin and heterochromatin (Jost et 
al., 2012; Mazzio and Soliman, 2012).  While the terms “heterochromatin” and 
“euchromatin” originates in early histological studies (Heitz, 1928; Jost et al., 2012; 
Levene, 1903), later studies have allowed for a definition based on molecular structure.  
Electron microscopy revealed that euchromatin is a linear array of nucleosomes without 
significant secondary structure or compaction of the linker DNA, and this state is often 
compared to “beads on string” (Jost et al., 2012; Mazzio and Soliman, 2012; Olins and 
Olins, 1974; Oudet et al., 1975; Woodcock and Dimitrov, 2001).  Euchromatic DNA can 
be readily accessed by transcription factors and ribosomes. The heterochromatin state 
consist of nucleosomes compacted together in higher order structures reducing the 
amount of space taken up by the bound DNA (Bednar et al., 1998; Jost et al., 2012; 
Woodcock and Dimitrov, 2001).  Generation of heterochromatin often involves the use of 
linker histones, which bridge between nucleosomes, to form and maintain a compacted 
structure (Bednar et al., 1998; Hamiche et al., 1996; Martins et al., 2012; Routh et al., 
2008; Whitlock and Simpson, 1976).  Aside from saving space, this compaction also 
serves as a layer of transcriptional repression (Lelli et al., 2012; Martins et al., 2012; 
Mazzio and Soliman, 2012).  This level of transcriptional regulation, mediated by the 
organization of DNA within the nucleus, is part of the field of epigenetics.     
Epigenetics refers to heritable modifications in the nature or structure of 
chromatin at a given locus (Mazzio and Soliman, 2012).  This does not involve changing 
the sequence of DNA, but rather changing the degree by which it can be accessed by 
transcriptional machinery.  Epigenetic changes can include chromatin remodeling, the 
changes in the conformation of the gene, and changes in the position of a gene within the 
nucleus.  The regulation of these conditions is an important determinant of the 
transcriptional activity of a given gene.   
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 The process of altering or removing nucleosomes to alter transcriptional 
accessibility is known as chromatin remodeling (Fry and Peterson, 2001; Mazzio and 
Soliman, 2012; Peterson, 2002).  Chromatin remodeling is carried out primarily by two 
classes of enzymes.  The first group modifies histone tails by the covalent attachment of 
methyl, phosphoryl, or acetyl groups (Allfrey et al., 1964; Cao et al., 2002; Langan, 
1969; Nislow et al., 1997; Nohara et al., 1968; Roguev et al., 2001). The effects of 
histone modifications on the transcriptional activity of a locus depend on which group or 
groups have been added and which residue of the histone is subject to modification 
(Mazzio and Soliman, 2012).  The acetylation of histones on lysine residues is a 
transcriptionally permissive modification (Fields et al., 2002; Hassan et al., 2002), and 
the effects of histone tail methylation vary depending on the residue and the number of 
methyl groups added.  Tri-methylation of histone 3 at lysine 4 (3me-H3K4) is found at 
histones of active promoters, and this modification is able to associate with TFIID and 
thus enhance transcription (Lauberth et al., 2013; Varier et al., 2010; Vermeulen et al., 
2007).  Conversely, tri-methylation of histone 3 at lysine 27 (3me-H3K27) is a strongly 
repressive mark able to recruit repressive transcription factors (Cao et al., 2002; Cavalli 
and Paro, 1998; Sewalt et al., 2002; Su et al., 2003).  The acquisition of histone 
modifications on nucleosomes associated with cytokine genes is a lineage specific event 
that occurs during T cell differentiation (Ansel et al., 2003; Fields et al., 2002).   
A second class of chromatin remodeling enzymes consists of ATPases that 
execute the modification of DNA-histone interactions.  This remodeling process can 
involve loosening the wrapping of DNA around a histone core, repositioning of a 
nucleosome by sliding it to an adjacent section of DNA, or eviction of a nucleosome from 
the DNA strand entirely (Gutiérrez et al., 2007; Hargreaves and Crabtree, 2011; Peterson 
and Workman, 2000; Steger and Workman, 1996; Yodh, 2013). Nucleosome 
repositioning preceding transcription can be demonstrated by the appearance of DNAse 
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hypersensitivity sites (HSS) and new micrococcal nuclease digestion product in cytokine 
genes being switched on during polarization (Takemoto et al., 2000; Zhang and Boothby, 
2006).  The appearance of these sites was shown to be due to the repositioning of 
nucleosomes at the inducible HSSs to allow for greater access by transcription factors 
and also to the DNAse enzyme (Almer et al., 1986; Narlikar et al., 2002; Peterson, 2002). 
Nucleosome repositioning is accomplished by multi-protein complexes typically 
containing a central ATPase, as well as multiple accessory proteins (Hargreaves and 
Crabtree, 2011). Chromatin remodeling complexes can exert both activating and 
repressing influences on transcription via compacting or opening up chromatin.  Several 
families of chromatin remodeling complexes have been reported (Fazzio and Rando, 
2012; Hota et al., 2013; Peterson and Workman, 2000; Yodh, 2013).  One family 
important in the regulation of Ifng transcription in T cells is the Swi/Snf family of 
chromatin remodeling complexes (Zhang and Boothby, 2006).  This chromatin 
remodeling complex can bind  directly to DNA (Wang et al., 1998), or to acetylated 
histone tails (Chandrasekaran and Thompson, 2007; Horn and Peterson, 2001; Singh et 
al., 2007).  The Swi/Snf complex is required to transcribe some genes, but also is crucial 
in the silencing of other genes such as CD4 (Chi et al., 2002).  In terms of cytokine gene 
regulation, Swi/Snf is typically associated with creating chromatin conditions favorable 
to transcription.  
One of the most studied repressive epigenetic modifications in the regulation of 
cytokine genes is the methylation of cytosine DNA bases in CpG dinucleotides.  CpG 
methylation can serve to recruit methyl-CpG-binding domain proteins (MBD proteins) 
(Defossez and Stancheva, 2011; Dhasarathy and Wade, 2008; Hung and Shen, 2003).  
MBD family members can then bind the NuRD complex to enact further repressive 
modifications such as increased nucleosome density and deacetylation of histone tails 
(Allen et al., 2013; Li et al., 2010; Saito and Ishikawa, 2002; Zhang et al., 1999).   CpG 
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methylation within the recognition sites for certain transcription factors can also inhibit 
transcription factor binding and transactivation (Jones and Chen, 2006; Sunahori et al., 
2009).  CpG methylation of regulatory regions of DNA is able to silence transcription by 
both direct and indirect mechanisms. 
    Methylation of CpG dinucleotides begins with the recruitment and activity of a 
de novo methyltransferase.  Two enzymes fill this role in mammalian cells, DNMT3a and 
DNMT3b (Deaton and Bird, 2011; Robertson et al., 1999).  In T cells, de novo 
methylation is carried out mainly by DNMT3a (Gamper et al., 2009).  Activation via the 
TCR greatly increases both the activity and absolute concentration of DNMT3a in the 
responding cell (Gamper et al., 2009).  The de novo methylation is carried out on one 
strand of the target sequence, but this allows the activity of the symmetry enforcing 
DNMT, DNMT1 (Bacolla et al., 1999; Bird and Wolffe, 1999; Pradhan et al., 1999).  
DNMT1 establishes symmetrical methylation during the initial methylation and is 
required to maintain the heritability of CpG methylation in actively cycling cells.    
The differentiation-dependent CPG methylation of a cytokine gene was first 
reported in the proximal Ifng promoter in Th2, but not Th1, cells (Fitzpatrick et al., 1998, 
1999; Melvin et al., 1995; Winders et al., 2004; Young et al., 1994).  The importance of 
DNA methylation in the silencing of cytokines from other effector lineages has been 
illustrated by transgenic mouse models defective in DNMT3a or DNMT1.  CD4
+
 T cells 
deficient in DNMT3a are unable to silence cytokine genes from other lineages, resulting 
in Th1 cells producing IL-4 or Th2 cells producing IFN-γ (Gamper et al., 2009; Thomas 
et al., 2012).  Methylation patterns in Th2 cells deficient for DNMT3a are very similar to 
the hypomethylated state found in naïve cells (Thomas et al., 2012).  Similarly, naïve 
cells deficient in DNMT1 produce exponentially more Ifng transcript than DNMT1-
sufficient cells upon ex vivo stimulation (Lee et al., 2001).  These experiments 
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demonstrate that the ability to repress cytokines from opposed lineages requires the 
ability to sustainably methylate cytokine genes.   
 
Regulation of the transcription of Ifng and Th2 cytokine genes in primary 
effectors: The Ifng gene 
                  For interferon gamma to be produced, STAT4 and T-bet signaling are 
insufficient.  Signaling pathways originating from the T cell receptor also are required for 
cytokine production.  The NFAT family of calcium-flux activated transcription factors 
has been shown to be essential for Th1 development and the production of IFN-γ, and the 
binding of NFAT1 isoforms to the Ifng promoter has been demonstrated via ChIP 
(Chromatin immunoprecipitation)  (Avni et al., 2002; Luo et al., 1996; Rooney et al., 
1994).  NF-κB signaling from the TCR is also required for Th1 differentiation and 
function.  Use of a dominant negative IκB protein (IκBαΔN)  showed T cell-intrinsic 
defects in IFN-γ production, as well as decreases in T-bet expression and STAT4 
activation (Corn et al., 2003).  Likewise, cells from mice deficient in the NF-κB subunit 
RelB had marked decreases in the ability to become functioning Th1 effectors, with 
defects in T-bet (Corn et al., 2005).    
A common element in many promoters, including the Ifng promoter, is the cAMP 
response element (CRE) which serves as a binding site for CREB/ATF transcription 
factors (Montminy et al., 1986).   CREB/ATF factors bind DNA as either homodimers or 
heterodimers, and can serve to activate or repress transcription of target genes (Cha-
Molstad et al., 2004; Wen et al., 2010).  Among the CREB/ATF factors which regulate 
Ifng transcription is CREB1.  Canonically, CREB1 is activated by PKA (protein kinase 
A), which has been shown to have a repressive effect on IFN-γ production (Shin et al., 
1998), but PKA-independent mechanisms of CREB phosphorylation have been 
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described, and two downstream effectors of the IL-12 receptor, p38 MAPK and Akt, have 
been shown to activate CREB (Johannessen et al., 2004; Pugazhenthi et al., 1999, 2000; 
Shankar et al., 2010).  Studies in mice or Jurkat cells produced conflicting results on the 
role of CREB1 in Ifng transcription (Cippitelli et al., 1995; Penix et al., 1996; Zhang et 
al., 1998a).  Work carried out in human CD4
+
 T cells responding to mycobacterial 
antigens showed CREB1 phosphorylation in cells actively producing IFN-γ (Liu et al., 
2010; Pasquinelli et al., 2009; Samten et al., 2005), and phospo-CREB1 has been shown 
to bind the Ifng promoter of human Th1cells in response to Mycobacterium tuberculosis 
(Samten et al., 2008).  This evidence supports a model in which CREB1 phosphorylation 
is carried out in a PKA-independent manner in Th1 effectors and can serve to 
transactivate the Ifng promoter in humans.               
Signaling from the TCR and CD28 also allows for the expression of the beta 
chain of the IL-12 receptor (IL-12rβ) (Wu et al., 1997).  The expression of a functional 
IL-12 receptor in turn allows for the activation of STAT4 (Jacobson et al., 1995; Manetti 
et al., 1993; Morinobu et al., 2002; Nishikomori et al., 2002) as well as the other effects 
of IL-12 receptor signaling discussed earlier. 
A naïve CD4+ T cell stimulated by its TCR under Th1 conditions does not 
immediately begin to produce IFN-γ.  A period of polarization is required to become a 
functioning effector cell (Lanzavecchia et al., 1999).  During this time multiple signaling 
networks and their downstream effectors act upon the Ifng promoter to prepare for 
transcription.  Signals from the TCR and co-receptors provide the initial burst of T-bet 
expression, as well as a transient peak of Ifng transcription (Ariga et al., 2007).  Early in 
the process of differentiation,  histone acetylation and other transcriptionally-permissive 
histone modifications occur at the Ifng promoter (Avni et al., 2002; Fields et al., 2002).  
These permissive Th1-specific histone modifications require the actions of T-bet and 
STAT4 for initiation and maintenance (Fields et al., 2002). 
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One effect of signaling through the aforementioned transcription factors is the 
chromatin remodeling of the Ifng promoter. During Th1 polarization, the Swi/Snf central 
ATPase Brg1 is recruited to the Ifng promoter (Zhang and Boothby, 2006), and it is 
known that both NFAT and STAT4 are essential for this remodeling to occur at the Ifng 
promoter in CD4
+
 T cells (Zhang and Boothby, 2006).  It may be that this remodeling is 
required for T-bet binding to the Ifng promoter.  Regulation of the activity of the Ifng 
promoter is accomplished by the synthesis of signals from the TCR and the cytokine 
receptors through the actions of multiple downstream pathways.  There is however 
another layer of control for the transcription of Ifng.                         
The interferon gamma gene is not controlled solely by the promoter.   Numerous 
elements flanking the coding regions also exert control over the transcription of Ifng.  
These conserved non-coding sequences (CNSs) serve to regulate the expression of Ifng.  
During Th1 polarization epigenetic changes can be observed at many of these elements, 
and several CNS regions have been found to bind to both subset-dependent and subset-
independent transcription factors (Hatton et al., 2006; Schoenborn et al., 2007).  Several 
of these elements also regulate Ifng transcription in a cell type-specific manner (Collins et 
al., 2012).    
Activation and repression of the Ifng gene both result from multiple signaling 
pathways initiated by the TCR, membrane-bound costimulatory receptors, and cytokine 
receptors.  These pathways trigger epigenetic changes at the promoter and multiple distal 
regulatory sites in order to promote gene expression or repression.                  
During the course of Th2 polarization, the Ifng gene is silenced by a variety of 
direct and indirect mechanisms.  Indirect silencing mechanisms include the repression of 
the IL-12 receptor and T-bet mediated by STAT6 and GATA3 (Ferber et al., 1999; 
Hosoya et al., 2010; Ouyang et al., 1998).   One of the best studied direct mechanisms for 
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silencing Ifng transcription is CpG methylation of the proximal Ifng promoter (Fitzpatrick 
et al., 1998, 1999; Melvin et al., 1995; Winders et al., 2004; Young et al., 1994).  As 
discussed previously, methylation of the Ifng promoter allows for repression by multiple 
mechanisms.    
Importantly, CpG methylation is able to directly inhibit the activity of the Ifng 
promoter, likely by inhibiting the binding of transcription factors required to transactivate 
the Ifng gene (cite).  Most notably, methylation of a single CpG dinucleotide located 53 
base pairs upstream from the transcription start site (C-53) was able to completely silence 
transcription from an Ifng-promoter construct (Jones and Chen, 2006).  The -53 CpG 
dinucleotide sits in the middle of a CREB/ATF binding site, and transcription factors 
unable to bind the methylated promoter were identified as CREB/ATF family members 
(Jones and Chen, 2006).  This demonstrates that promoter methylation is capable of 
regulating transcription in the absence bound inhibitory transcription factors.               
                   
Regulation of the transcription of Ifng and Th2 cytokine genes in primary 
effectors: The Th2 cytokine locus 
The regulation of the Th2 cytokine locus differs from what is seen at the Ifng gene 
in many key details.  The mechanisms controlling the production of IL-3, IL-4, IL-5, and 
IL-13 are a fertile area of research which will only be touched upon briefly here.  As 
opposed to Th1 development, Th2 polarization involves the activation of several cytokine 
genes within the Th2 cyokine locus (Ansel et al., 2006; Fields et al., 2004).  IL-3, IL-4, 
IL-5, and IL-13 each have their own regulatory regions including promoters, but also are 
under the control of a locus control region (LCR) located at the 3’ end of the RAD50 
gene (Lee and Rao, 2004; Lee et al., 2003).  This provides a central control for execution 
of the Th2 effector program.     
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A second difference between Ifng and the Th2 cytokine locus is that the Il4 
promoter, the  region of the LCR, and regions between the Il4 and Il13 genes are 
methylated in naïve T helper cells (Ansel et al., 2006; Lee et al., 2002).   During Th2 
polarization, this methylation is lost, possibly as a consequence of cell division without 
enforcement of symmetry (Ansel et al., 2006; Kim et al., 2007; Lee et al., 2002).  The 
regulation of Th2 cytokine genes therefore has differences far beyond the requirements 
for lineage-specific transcription factors.    
 
T cell memory  
 One key feature of the adaptive immune system is the ability to ‘remember’ 
antigens by allowing a small number of responding B and T cells to survive past the point 
of pathogen clearance and antigen withdraw.  In the post-effector state, activated T cell 
clone populations contract, and surviving cells reach a semi-quiescent state.  The onset of 
the memory phenotype appears to occur soon after antigen withdraw, although the exact 
time required for an active cell to become a true memory cell remains unknown  (Dooms 
and Abbas, 2006; Hu et al., 2001; Swain, 1994)  
 Memory T cells quickly reacquire an active phenotype upon re-exposure to 
antigen, and begin expanding and producing cytokines days before antigen responsive 
naïve cells (Croft et al., 1994).  These memory cells allow the immune system to respond 
rapidly to subsequent exposures to a given antigen and provide prophylaxis against repeat 
infections with the same pathogen.  The initial response taken by CD4
+
 memory cells 
upon restimulation is to produce the cytokines associated with the effector subset from 
which it is derived, demonstrating that some commitment to a given cell fate is 
maintained in memory cells (Cerottini and MacDonald, 1989; London et al., 1999, 2000).  
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The formation and behavior of memory population is central to the development of 
vaccines and to the general function of the adaptive immune system (Kaech et al., 2002).      
Two models are used to explain the development of memory cells from an antigen 
stimulated population of T cells (Fig. 1.4).  The first model, called the linear 
differentiation model (Fig. 1.4A) has a memory population arising from fully 
differentiated effector cells.  The partial differentiation model (Fig. 1.4B)  has two 
populations developing during the course of polarization (Wu et al., 2002).  The first is an 
effector population which dies off during clonal contraction following antigen clearance.  
The second population does not have as robust effector function, but maintains the 
epigenetic programing of the effector population.  Cells of this partially-differentiated 
population survive to form a memory population.       
For CTL memory cells, the evidence supports a model of development from 
partially-differentiated precursor cells.   Division of CD8
+
 T cells upon interaction with 
an APC expressing cognate antigen is reported to occur asymmetrically, with the 
proximal daughter cell expressing higher levels of CD8 and effector cytokines (Chang et 
al., 2007).  The distal daughter cells were smaller and exhibited expression of surface 
markers associated with CD8
+
 memory cells (Chang et al., 2007).   This asymmetric 
division of activated CD8
+
 T cells also differentially partitions the T-box transcription 
factors eomesodermin and T-bet between the daughter cells.  T-bet protein is primarily 
partitioned in the proximal, effector-like daughter cell, while eomesodermin is localized 
to the distal, memory-like daughter cell (Chang et al., 2011).  The eomesodermin
Hi
 
daughter cells produce less  IFN-γ than the T-bet
Hi
 daughter cells, but survive much 
better in the long term, and can give rise to a memory population (Banerjee et al., 2010; 
Intlekofer et al., 2005).  Subsequent divisions enhance the effect of this partitioning, and 
the relative amounts of eomesodermin and T-bet have been shown to have a predictive 
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value as to which daughter cells will survive as memory cells (Banerjee et al., 2010; 
Intlekofer et al., 2005; Rao et al., 2010).      
In the case of CD4
+
 T cells, the source of memory cells may depend on the 
effector type.   For Th2-derived memory cells, the linear differentiation model is 
supported by experimental evidence.  IL-4 producing Th2 effectors generated in vitro and 
transferred to recipient mice  have been shown to give rise to a long-lived post-effector 
population in vivo, demonstrating that Th2 cells progress from an effector state to a 
memory state (Adeeku et al., 2008; Löhning et al., 2008).  The source of Th1 memory 
has been a point of contention, with some data supporting the direct model (Swain, 1994) 
and other data supporting a model of partial differentiation similar to that found in CTL 
memory (Ahmed and Gray, 1996; Kaech et al., 2002; Moulton and Farber, 2006).  In 
particular, Th1 cells expressing less Ly6c and T-bet have been found to persist longer and 
respond better to secondary antigen exposure (Marshall et al., 2011).  The similarities 
between findings in Th1 cells and CD8
+
 cells suggests that partial differentiation may be 
a result of IFN-γ production (Stockinger et al., 2006).      
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Figure 1.4 Alternative models of T cell memory.  Shown are the linear (A) and partial 
differentiation (B) models of T cell memory formation.     
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Regulation of cytokine genes in the memory phase 
Memory cells are able to rapidly produce cytokines a secondary exposure to 
antigen.  Whether this is due to differences in the regulation of cytokine genes or the 
maintenance of a ‘primed’ chromatin state has been the subject of study.   In the case of 
CD8
+
 cells, studies on the regulation of the Ifng promoter have revealed a degree of 
dynamism of CpG methylation.  A naïve CTL has an Ifng promoter that is predominantly 
CpG methylated and is unable to produce IFN-γ (Fitzpatrick et al., 1998).  During the 
course of cell divisions undertaken after activation, methylation of the Ifng promoter is 
lost from the population and the ability to produce IFN-γ is acquired (Fitzpatrick et al., 
1998, 1999).  Importantly, DNA methylation of the Ifng promoter is re-established in 
CD8
+
 memory populations, but rapidly lost upon restimulation (Kersh et al., 2006).  This 
loss of CpG methylation, occurring in about five hours, correlates with the renewed 
production of IFN-γ (Kersh et al., 2006).  This suggests that methylation of the Ifng may 
not be the stable repressor that it is commonly portrayed as being.            
For memory cells derived from Th2 effectors, the transcriptional readiness of the 
Th2 cytokine locus is actively maintained (Yamashita et al., 2006), even in the absence of 
cytokine signaling (Yamashita et al., 2004). The expression of GATA3 at high levels is 
also actively maintained in Th2 memory cells.  The transcription factor MLL has been 
shown to be essential for the maintenance of GATA3 expression and permissive histone 
modifications on the Th2 cytokine locus (Yamashita et al., 2006).  Reduction of MLL 
expression in CD4
+
 cells has also been demonstrated to impair the formation of Th2 
memory, but not effector, populations (Yamashita et al., 2006).  These data demonstrates 
that MLL is at least indirectly responsible for the maintenance of Th2 lineage 
commitment, and suggest a continued requirement for the expression of GATA3.       
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Regulation of cytokine genes in the memory phase: Flexibility 
While commitment to express IL-4 was maintained in the memory phase, these 
Th2-derived memory cells could also produce significant amounts of IFN-γ 
simultaneously with IL-4 when restimulated under Th1-polarizing conditions (Adeeku et 
al., 2008; Krawczyk et al., 2007; Löhning et al., 2008).   Further research in mouse 
models identified IL-12 signaling, T-bet expression, and signaling from type-I interferons 
as essential to the flexible production of IFN-γ, and reported IFN-γ producing cells as 
still expressing GATA3 (Hegazy et al., 2010).  Work in human cells has shown that    
IFN-α/β can inhibit GATA3 expression and thus abrogate IL-4 production in Th2 effector 
cells (Huber et al., 2010). This suggests that there is either a difference in this regard 
between mice and humans or between memory and effector cells.     
The ability of Th2-derived memory cells to produce a cytokine inimical to Th2 
function such as IFN-γ raises many questions.  It is currently unknown if the methyl-CpG 
mediated repression of the Ifng promoter formed in Th2 differentiation is maintained in 
Th2 memory cells.  Several possible models explaining the reported flexibility of IFN-γ 
production can be put forth.  In the first, the repressive DNA methylation of the Ifng 
promoter is established in polarization, but lost sometime between antigen withdraw and 
restimulation.  The second is that the repression of the Ifng promoter is maintained in 
memory phase but overcome by Th1 signaling, as it has been demonstrated that 
exogenous T-bet can transactivate a fully methylated Ifng promoter (Tong et al., 2005).  
The third model is that DNA methylation is maintained in memory cells, but lost upon 
restimulation under Th1 conditions.  Identification of the correct model is crucial to 
furthering our understanding of the molecular underpinnings of flexibility in memory 
cells and the stability of CpG methylation in T helper cells.   
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A second unknown is whether STAT4 is required for the expression of Ifng by 
Th2-derived memory cells.  While IL-12 has been identified as essential for flexibility 
(Adeeku et al., 2008; Hegazy et al., 2010), it remains unclear if STAT4 is involved in 
flexibility.  IL-12 signals through multiple pathways, many of which can impact Ifng 
transcription without STAT4 (Rao et al., 2010, 2012; Yoo et al., 2002).  The absence of 
STAT4 activation would imply a mechanism of Ifng transcription vastly different from 
that seen in naïve cells acquiring Th1 effector function.  Finally, it remains to be seen 
whether either T-bet or STAT4 has any bearing on the initiation or maintenance of the 
DNA methylation at the Ifng promoter. 
The extra adaptability that flexible cytokine expression brings to the CD4
+
 
component of the adaptive immune system is still poorly understood in terms of both 
mechanism and significance.  The uniqueness of this reprograming of differentiated 
somatic cells without recourse to the highly artificial methods used to create induced 
stem cells (Adachi and Schöler, 2012; Takahashi et al., 2007) or to trans-differentiate 
committed cells into a new lineage (Sundrud et al., 2003; Zhou et al., 2008) makes 
understanding the mechanisms underlying plasticity of cytokine expression important.  
Likewise, an understanding of the significance of plastic cytokine expression in T helper 
cells will allow us to better grasp the nature of an adaptive immune response from 
initiation to memory to recall.  This work aims to identify mechanisms and requirements 
for the flexible expression of Ifng by memory cells derived from fully differentiated Th2 
effectors.   Understanding the mechanisms underlying this natural reprograming will add 
new depth to our understanding of cell fate commitment, gene regulation, and the 
function of T helper memory.                          
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II. HEMIMETHYLATION OF THE Ifng PROMOTER IN TH2 EFFECTOR 
CELLS 
Strand-biased acquisition of Ifng promoter methylation in Th2 effector cells 
The flexibility of cytokine expression demonstrated by Th2-derived memory cells 
acquiring the ability to produce IFN-γ (Adeeku et al., 2008; Löhning et al., 2008) raised 
several questions central to the understanding of lineage commitment in the post-effector 
phase.  The first of these which we addressed was whether the inhibitory CpG 
methylation of the Ifng promoter reported in effector Th2 cells (Jones and Chen, 2006; 
Melvin et al., 1995; Yano et al., 2003; Young et al., 1994) was maintained in the memory 
phase.  At the outset, we formulated two hypothetical models.  In the first model, 
methylation remained, but the repressive effects were overcome during the course of the 
recall response.  This model was supported by the observation that expression of T-bet 
could transactivate a methylated Ifng promoter (Tong et al., 2005).  The second model 
was that, in the time between the initial response and the recall response, methylation of 
the Ifng promoter was lost.  In CD8
+
 cells, loss of Ifng promoter methylation has been 
reported (Kersh et al., 2006), but no studies had  investigated Ifng promoter methylation 
in CD4
+
 memory cells.  Also supporting this model was research showing that the global 
DNA methylation in memory cells was decreased, as was the expression of DNA 
methyltransferases (Li et al., 2012).  To investigate this, we turned to bisulfite DNA 
modification followed by strand-specific PCRs (Fig. 2.1A) as a means to detect and 
quantify CpG methylation.                 
We began by analyzing DNA from naïve CD4
+
 T cells, Th1 effectors (13 days 
post stimulation), and Th2 effectors for methylation of the Ifng promoter (Fig. 2.1B).   
Naïve CD4
+
 and Th1 effector cells showed little methylation of either strand of DNA 
upstream from the transcription start site (Fig. 2.2), whereas high methylation densities 
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were found at two dinucleotides in exon 1, independent of T cell differentiation, as 
expected (Deaton et al., 2011; Maunakea et al., 2010).  In effector Th2 cells (Fig. 2.2), we 
found increased methylation of the coding strand of the Ifng promoter, with a majority of 
samples exhibiting modification of the -53 CpG whose modification was reported to 
abrogate promoter activity (Jones and Chen, 2006).  Surprisingly, however, the 
noncoding strand was reproducibly and significantly less methylated in Th2 effector cells 
relative to the coding strand (Fig. 2.3), particularly at the -53 CpG (Fig. 2.3D). In light of 
this unexpected result, we tested samples including DNA from a mouse brain and 3T3 
cells, both of which would be expected to have symmetrical hypermethylation of the Ifng 
promoter, along with thymocytes, which are reported to have symmetrical 
hypomethylation.  Brain and 3T3 cell DNA demonstrated a high density of methylation 
symmetrically across the surveyed region and in particular at the crucial -53 CpG.   
Thymocytes, like naïve CD4 T cells, exhibited little CpG methylation (Table 2.1). The 
frequency of non-coding strand DNA methylation in Th2 cells was too low simply to 
represent a lack of modification on one chromosome, e.g., from mono-allelism (Bix and 
Locksley, 1998).  Separate analyses (Table 2.1 and later results) exclude a strand bias in 
the detection method as the basis for the observation. Accordingly, we infer from these 
data that Ifng promoters were hemimethylated in these Th2 effector cells. 
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Figure 2.1. Bisulfite modification for the detection of CpG methylation.  A. 
Schematic of bisulfite sequencing work-flow.   Isolated DNA is reacted with sodium 
bisulfite, resulting in all unmethylated cytosine bases being converted to uracils.  The C 
to U base mutation results in the two DNA strands no longer being reverse complements 
to each other.  This in turn allows for PCR analysis of each strand individually.    B.  Map 
of the Ifng promoter region assayed by bisulfite sequencing.  CpG dinucleotide positions 
are given relative to the transcription start site (TSS).    
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Figure 2.2.  Methylation of the Ifng promoter is lineage-specific.  The results of 
bisulfite sequencing  analysis of  DNA from naïve CD4
+
 (A), Th1, and Th2 (B) effectors 
demonstrate lineage specific methylation.  Each  row of the above plots represents one 
sequenced clone, with filled dots representing a methyl-CpG.  Results are representative 
of two (A) or three (B) biological replicates.   
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Figure 2.3. Asymmetric methylation of the Ifng promoter in Th2 effectors.  A.  
Schematic of the Ifng promoter. B. Quantification of the methylation of all CpG 
dinucelotides upstream of the TSS, CpGs -205 to -170, and -53 to -32 across two (naïve) 
or three (Th1 and Th2) biologically independent replicates.  Methylation frequencies are 
compared for Th1, Th2, and naïve cells for the coding (upper left) and non-coding strands 
(upper right).  C.  Methylation of the coding strand is significantly higher than the non-
coding strand in Th2 effectors (lower left).   D.  Methylation of the -53CpG is highly 
strand and lineage specific.  Shown are means ±S.E.M. *p<0.05, ** p<0.01, ***p<0.001.  
D. C. 
51 
 
Table 2.1.   CpG methylation in naïve CD4
+
 T cells, thymus, brain, and NIH 3T3 
cells 
 
A. 
  CpG position
a
 
Sample Strand -205 -190 -170 -53 -45 -34 16 
Naïve CD4 
 
Coding 11.4 (3.6)
b 
11.4 (3.6) 14.4 (3.6) 17.4 (3.9) 14.4 (3.6) 14.4 (3.6) 59.8 (6.1) 
 
Non-coding 17 (3.6) 10.8 (1.6) 6.25 (2.3) 17 (3.4) 15.3 (2) 15.3 (2) 90.9 (3.6) 
Thymus 
 
Coding 0 0 0 0 0 0 72.2 (3.5) 
 
Non-coding 0 0 0 0 0 0 71.3 (3.5) 
Brain 
 
Coding 100 86.6 (2) 86.6 (2) 100 100 100 100 
 
Non-coding 95 (2.7) 76.7 (3) 100 95 (2.7) 100 91.7 (3.3) 83.3 (4.9) 
NIH 3T3 
Coding 78.9 (3.2) 63.1 (3.8) 52.6 (1.8) 63.1 (0.9) 63.1 (0.9) 52.6 (3.5) 68.4 (2.8) 
 
Non-coding 62.5 (4.2) 36.3 (6.1) 43.8 (3.0) 56.3 (3.0) 50 (0.0) 50 (0.0) 87.5 (4.2) 
 
B.   
Sample Strand Total
c 
-205-170 -53-34 
Naïve CD4 
Coding 0.9 (0.25)
d 
0.4 (0.18) 0.52 (0.2) 
Non-coding 0.7 (0.34) 0.25 (0.14) 0.45 (0.22) 
Thymus 
Coding 0.11 (0.07) 0 (0) 0.11 (0.07) 
Non-coding 0 (0) 0 (0) 0 (0) 
Brain 
Coding 5.7 (0.12) 2.7 (0.12) 3 (0) 
Non-coding 5.6 (0.16) 2.6 (0.15) 2.9 (0.06) 
3T3 
Coding 3.8 (0.45) 2.1 (0.27) 1.8 (0.31) 
Non-coding 2.9 (0.53) 1.4 (0.26) 1.5 (0.35) 
 
a:  position is presented as the distance in bases from the transcription start site  
b:  data are presented as the mean (± SEM) percentage of samples methylated at a given 
position.   
c: Cluster of CpG dinucleotides being assayed.   
d. Mean (± SEM) number of methyl-CpGs per clone in a given cluster.  
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Hemimethylation occurs naturally during the course of DNA replication (Bhutani 
et al., 2011; Ehrlich and Wang, 1981; Tatematsu et al., 2000), and we wished to verify 
that the hemimethylation we were detecting was not due to DNA synthesis and cell 
division.  Therefore, we measured the amount of DNA synthesis at the time of DNA 
extraction via BrdU uptake and cell division activity via CFSE partitioning (Fig. 2.4).  
We detected little to no cell division or BrdU incorporation at the time of DNA 
extraction, and so we conclude that the hemimethylation of the Ifng promoter is not due 
to DNA replication, but rather is a unique feature of gene transcriptional regulation in 
Th2 cells.   
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Figure 2.4.  Th2 effectors have exited cell cycle at the time of DNA methylation 
analysis.   Th2 cultures were analyzed for CFSE partitioning (B) and BrdU uptake (C).  
(A) Schematic showing the partitioning of CFSE over the course of multiple cell cycles.  
(B) CFSE labeling occurred either at the time of stimulation (day 2 samples) or on day 11 
(day 13 samples).  After 48 hours the CFSE staining profiles of the samples were 
compared.  (C). Th2 cultures either 2 or 13 days after initial stimulation were pulsed with 
BrdU for four hours and then stained to determine BrdU incorporation into DNA.  Cells 
grown continuously in the presence of BrdU serve as a positive control for BrdU staining, 
while cells left untreated serve as a negative control.    
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SnaBI digestion is sensitive to hemimethylation 
Previous studies have used the methylation sensitive restriction enzyme SnaBI to 
detect CpG methylation at the Ifng promoter (Melvin et al., 1995; Winders et al., 2004; 
Young et al., 1994).  The -53 CpG is within a SnaBI cleavage site, meaning that 
methylation at this dinucleotide would prevent SnaBI from digesting DNA.  While this 
has been verified with symmetrically methylated DNA, the effects of hemimethylation 
are unknown.  If SnaBI is hemimethylation sensitive, then an enzymatic digest would not 
be able to discriminate between symmetric and asymmetric methylation.  This would 
explain in part why the strand-specific methylation we describe has not been previously 
reported.  To determine if SnaBI digestion is inhibited by hemimethylation, we used 
probes consisting of the region of the Ifng promoter encompassing the proximal three 
CpG dinucleotides (C-53, C-45, C-34) (Fig. 2.6A, Table 5.1).  Probes were either 
unmethylated or methylated at C-53 on the coding strand.  These probes were digested 
with SnaBI, and the extent of cleavage was assayed via autoradiograph.   We found that 
while SnaBI is able to cut the unmethylated probe, the methylation of C-53 on the coding 
strand significantly inhibits digestion (Fig. 2.5).  This finding suggests that any assays of 
DNA methylation in the Ifng promoter using SnaBI would be unable to distinguish 
between symmetrical and asymmetric methylation and possibly explains why 
hemimethylation of the Ifng has not been previously reported.       
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Figure 2.5. SnaBI digestion is inhibited by hemimethylation at C-53. Unmethylated 
(center lane) or C-53 probes (right lane) (Fig. 2.6A, Table 5.1) were labeled with 
32
P and 
then digested to completion with SnaBI.  The reactions were resolved via electrophoresis 
on a 20% acrylamide gel and visualized via autoradiography.  Undigested, radiolabeled 
probe (left lane) was included as a negative control for digestion. 
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Asymmetrical methylation impacts transcription factor binding to the Ifng 
promoter 
The -53 CpG dinucleotide is situated in a CREB/ATF binding site (Jones and 
Chen, 2006) and adjacent to a known T-bet binding site (Tong et al., 2005).  Previous 
work had demonstrated that the binding of members of the CREB/ATF family of 
transcription factors could be inhibited by symmetric DNA methylation (Jones and Chen, 
2006; Sunahori et al., 2009), but little was known about the effects of hemimethylation 
on transcriptional regulation.  Therefore, we investigated whether hemimethylation could 
impact the ability of transcription factors to bind the Ifng promoter.  
To determine the effects of coding-strand specific methylation of the Ifng 
promoter on the formation of protein-DNA complexes, we performed electrophoretic 
mobility shift assays (EMSA) using the hemimethylated and non-methylated probes 
based on the Ifng promoter as described above, along with a probe having all three 
proximal CpGs methylated on the coding strand (Fig. 2.6A, Table 5.1).  Hemimethylation 
of the -53 CpG or of all three CpG dinucleotides in the probe impaired the formation of 
the slower migrating complex (Figure 2.6B, filled arrow).  To determine the effects of 
hemimethylation on the relative affinity of the slower migrating complex, we turned to a 
competition assay using labeled unmethylated probe (Fig. 2.7).  Competition assays using 
unlabeled competitor DNA and labeled unmethylated probed confirmed that the mobility 
shift bands represented sequence-specific binding.  Moreover, 10-fold more 
hemimethylated cold competitor (relative to unmethylated probe) was needed to attenuate 
probe binding to the slower complex (Fig. 2.7).  Quantification of the results of three 
such experiments combined with regression modeling verifies that hemimethylation 
intereferes with th binding of proteins to the Ifng promoter (Fig. 2.8).   
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Figure 2.6: Inhibition of protein-DNA interaction by hemimethylation.   A.  Probes 
based on the Ifng promoter were generated with no methylation (top), methylation at the  
-53 C nucleotide of the coding strand, or with methylation of the -53, -45, and -34 C 
nucleotides of the coding strand.  B) Electrophoretic mobility shift assay (EMSA) using 
nuclear extract from primary Th1 cells shows two bands (upper and lower arrowheads) 
with the unmethylated probe, and altered complex formation with the hemimethylated 
probes.   
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Figure 2.7. Effects of hemimethylation on protein-binding affinity.  Competition 
assays were carried out with radiolabeled unmethylated probe, and either an equimolar, 
10-fold excess, or 100-fold excess of competitor.  Results are representative of three 
experiments.  
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Figure 2.8.  Calculation of relative affinities of unmethylated and C-53 
hemimethylated (1xMe) probe.  Results from three independent experiments were 
quantified, and regression equations were used to extrapolate the concentration which 
would yield complete inhibition ([I]max).   
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In order to identify the slower migrating complex, we then employed antibody 
blocking/supershift assays using antibodies against CREB1, ATF2, and c-Jun (Fig.  2.9).   
Only the CREB1 antibody affected the formation and position of the slower migrating 
complex, from which we inferred that the hemimethylation-sensitive transcription factor 
was CREB1.  
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Figure 2.9. Identification of the slower migrating band as a CREB1 containing 
complex.  Electrophoretic super-shift assays were carried out using normal IgG, anti-c-
Jun, anti-CREB1, and anti-ATF2.   
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CREB1 and the Ifng promoter 
 After identifying CREB1 as a transcription factor capable of binding 
unmethylated, but not hemimethylated probes derived from the Ifng promoter, we then 
set out to determine the functional significance of CREB1 in the regulation of IFN-γ 
production.  If the recruitment of CREB1 to the Ifng promoter is regulated by 
hemimethylation, we would expect it to be present at the Ifng promoter in Th1 but not 
Th2.  To test this hypothesis, we preformed chromatin immunoprecipitations (ChIPs, see 
Fig. 5.1 for workflow) with an anti-CREB1 antibody and an anti-acetyl histone H3 
antibody as a control for precipitation (Fig. 2.10).  We were able to detect CREB1 
occupancy at the Ifng promoter in Th1 cells, but not Th2 cells, demonstrating a lineage 
specific recruitment of CREB1.   
As CREB1 is recruited to the Ifng promoter in a Th1-specific,  methylation-
sensitive manner, we then wished to determine what effects CREB1 exerted on promoter 
activity.  To this end, we nucleofected primary Th1 cells with a minimal Ifng promoter 
reporter luciferase construct alongside either a CREB1 expression vector or an empty 
vector control (Fig. 2.11).  We found a striking increase in reporter activity in CREB1 
nucleofected samples relative to empty vector controls, demonstrating that CREB1 is 
capable of transactivating a minimal Ifng promoter.  One signaling pathway known to 
activate CREB/ATF family members is the cAMP responsive protein kinase-A (PKA).  
Interestingly, activation of PKA via dibutyrl-cAMP (db-cAMP) has been shown to inhibit 
the production of IFN-γ (Bartik et al., 1994; Shin et al., 1998).  We therefore set out to 
test what effects exogenous expression of CREB1 would have in cells treated with       
db-cAMP.  We found that db-cAMP was unable to repress reporter activity in CREB1 
nucleofected samples (Fig. 2.12).  This result suggests that the repressive effects of PKA 
activity are mediated by other transcription factors than CREB1, although more work is 
63 
 
needed to determine the relationship between CREB1 and PKA signaling in the 
regulation of IFN-γ production.   
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Figure 2.10. CREB1 is recruited to the Ifng promoter in Th1, but not Th2 cells.  
ChIPs for CREB1 and Ac-H3(K9) were carried out on chromatin from primary Th1 and 
Th2 effectors.  Results are shown as a representative image (A.), and were quantified via 
phosphor imaging to determine the precipitated DNA as a percent of input (B).  Results 
are from three independent experiments.  **p<0.01   
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Figure 2.11. CREB1 can transactivate a minimal Ifng promoter.  Primary Th1 cells 
were nucleofected with a minimal Ifng promoter-luciferase construct and pSport6 or pSport6-
CREB1, luciferase activities were normalized to GFP expression. Shown are mean (± SEM) data 
from three independent experiments. (* p ≤ 0.05)  
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Figure 2.12: Dibutyrl-cAMP driven inhibition of Ifng promoter activity is blocked 
by exogenous CREB1 expression.  Th1 effectors were nucleofected as in Fig. 2.11, and 
then treated with 5μM db-cAMP for four hours.  Luciferase activity was then measured 
and normalized to GFP expression.  The resting samples were reproduced from Fig. 2.11. 
Results shown are from three independent experiments.  (*** p<0.001)         
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Conclusions 
 In this chapter we have described a novel and functional epigenetic modification 
of the Ifng promoter that is reproducibly found in Th2, but not Th1, effectors.   We have 
shown that the DNA methylation of the Ifng promoter occurs preferentially on the coding 
strand as naïve cells develop towards a Th2 effector fate.  We have also shown that this 
asymmetric methylation is sufficient to inhibit the binding of transcription factors.  We 
have identified CREB1 as a hemimethylation-sensitive transactivator of the Ifng promoter 
that is present at the promoter in Th1, but not Th2 cells.  Furthermore, while we have 
reproduced  reported data in which the PKA-agonist db-cAMP decreased transcription 
from  an Ifng promoter-based construct (Shin et al., 1998), we have also  shown that 
exogenous expression of CREB1 blocks the inhibitory action of db-cAMP.   From this, 
we infer that activation of CREB1 during Th1 responses is accomplished by              
PKA-independent mechanisms.   
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III. REGULATION OF IFN-γ PRODUCTION IN Th2 MEMORY CELLS 
Absence of promoter methylation in Th2-derived memory cells 
 Given our findings of asymmetric methylation at the Ifng promoter in Th2 
effectors, we then wished to determine if the methylation status of the Ifng promoter in 
memory Th2 cells.   Th2-derived memory cells were generated as per our previous work 
(Adeeku et al., 2008), and  the process is summarized in Figure 3.1.   DNA was extracted 
from cells at the time of transfer (Th2 effector samples) and upon recovery 4-8 weeks 
after transfer into either athymic (BALB/c nude) or wildtype BALB/c recipients.  As 
expected, cells transferred into both recipient types underwent homeostatic expansion 
(Fig. 3.2) and acquired the ability to produce IFN-γ after restimulation and growth under 
Th1 conditions (Figure 3.3).   
 Strand-specific analysis of DNA methylation in DNA recovered from purified 
memory cells showed a decrease in CpG methylation across the coding strand of Ifng 
promoter (Fig. 3.4 and 3.5), and little change in the methylation density of the non-coding 
strand.   Most strikingly, coding strand methylation of the crucial -53CpG was almost 
entirely absent in all analyzed sequences (Fig. 3.5B).  Given that cells have divided post-
transfer as previously discussed, we have developed a model in which the 
hemimethylation in Th2 effectors is diluted out over the course of multiple cell divisions, 
allowing for a passive, promoter specific mechanism of demethylation (Fig. 3.6).       
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Figure 3.1. Generation of memory cells from IL-4 producing Th2 effectors.  
Schematic of memory cell generation.  Splenocytes expressing the transgenic DO11.10 
receptor and the 4get bicistronic IL-4 reporter allele are raised under Th2 conditions for 
four days.  The cells are then sorted for CD4
+
, DO11.10
+
, GFP
+
 cells.  These are 
expanded for a week, and then transferred into a recipient (DO11.10 negative) mouse.  
After 6-8 weeks, recipient mice are harvested, and memory cells are identified via the 
DO11.10 TCR.  Inset: Flow cytometric plot for GFP in expressed in Th1 (solid) and Th2 
(outline) effectors.  
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Figure 3.2: Homeostatic expansion in BALB/c and BALB/c Nude recipients.  A.  
Schematic of CFSE partitioning as a means to track division history in a cell population.  
Th2 cells were labeled with CFDA-SE and transferred into recipient mice.  Shown are the 
CFSE staining profiles of donor-derived cells recovered from wildtype (shaded) and 
Nude (outline) recipients twelve days post-transfer.  Results are representative of two 
independent experiments.   
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Figure 3.3.  IFN-γ production in Th2-derived memory cells.  Th2-derived memory 
cells were restimulated for 36 hours with peptide+APCs at the time of recovery (initial) 
and after one week of restimulation under Th1 or Th2 conditions, and the concentration 
of IFN-γ in the supernatant was measured.  Results are shown as picograms of IFN-γ 
produced per 1,000 donor-derived (DO11.10 TCR
+
 CD4
+
) cells, and are representative of 
four independent experiments consistent with previous studies (Adeeku et al., 2008; 
Löhning et al., 2008).  
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Figure 3.4. Absence of coding strand methylation in memory Th2 cells.  Shown are 
representative sequences of bisulfite modified DNA as in Figure 2.2.  Results are from 
four independent experiments.   
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Figure 3.5.  Quantification of methylation of the Ifng promoter in Th2-derived 
memory cells.  A. . Quantification of the methylation of all CpG dinucelotides upstream 
of the TSS, CpGs -205-170, and -53-34.  Shown are the mean of four independent 
experiments (±SEM). B.  The mean (±SEM) frequency of methylation at the -53CpG 
dinucleotide in Th2 memory cells is shown, with effector data from Fig. 2.2 shown for 
comparison     *p<0.05, ** p<0.01, ***p<0.001. 
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Figure 3.6. A model of cell division dependent passive demethylation. Shown is a 
model of demethylation in which hemimethylation is diluted out over the course of 
successive cell divisions.  
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Requirement for STAT4 in flexible production of IFN-γ 
The development of Th1 effector cells from naïve CD4
+
 T cell precursors is 
highly dependent on IL-12-induced STAT4 and, in most settings, on T-bet (Jacobson et 
al., 1995; Szabo et al., 2000, 2002). IL-12 is required for the facultative induction of  
IFN-γ production by memory Th2 cells after recall stimulation in vitro and in vivo 
(Adeeku et al., 2008; Hegazy et al., 2010; Löhning et al., 2008).  However, the IL-12 
receptor elicits multiple intracellular signals (Fig. 1.3) (Rao et al., 2012; Yoo et al., 
2002), and which of these pathways are essential for the plasticity of gene expression is 
not known.    
To investigate whether STAT4 is required for the production of IFN-γ by Th2-
derived memory cells we generated memory cells from STAT4 deficient or T-bet 
deficient Th2 effectors and compared the amount of IFN-γ produced upon initial 
restimulation with antigen, along with that produced after one week of expansion under 
Th1 or Th2 recall conditions.  After one week of Th1 culture, neither STAT4-deficient 
nor T-bet deficient Th2 memory cells secreted as much IFN-γ upon restimulation with 
peptide antigen and APC as the matched wildtype control.  However, the amount of    
IFN-γ detected in the supernatants of the transcription factor deficient cells still was 
above the background of the assay (Fig. 3.7).  Comparison of the relative amounts of 
IFN-γ produced in each experiment revealed that cultures of T-bet deficient or      
STAT4-deficient memory cells consistently produced about 30% of the IFN-γ secreted 
by the matched wildtype control (Fig. 3.8).   This finding was consistent between cells 
recovered from both athymic nude mice and from wildtype recipients (Figure 3.8).  
Intracellular cytokine staining showed that upon recovery, all three genotypes maintain 
commitment to produce IL-4 upon recall stimulation (Fig. 3.9A), but approximately 31% 
of wildtype donor-derived cells have become IFN-γ
+
, IL-4
+
 double producers after 1 
week of Th1, but not Th2 recall culture (Fig. 3.9B).  Furthermore, no IFN-γ production 
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could be detected via ICCS in T-bet or STAT4-deficient Th2 memory cells, even after 1 
week of Th1 culture (Fig. 3.9B).  These findings demonstrate that STAT4 is required for 
the flexible expression of the Ifng gene and confirm previous reports that T-bet is also 
required (Hegazy et al., 2010).
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Figure 3.7. IFN-γ secretion is impaired in T-bet or STAT4 deficient Th2-derived 
memory cells.  The mean (±SEM) amount of IFN-γ (in pg) secreted by 1,000 cells in 36 
hours is shown at the time of harvest (initial), and after one week of Th1 or Th2 recall 
conditions.  Shown are the averages for at least 6 independent experiments.   
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Figure 3.8.  IFN-γ production of T-bet or STAT4-deficient Th2 memory cells 
relative to wildtype Th2 memory cells.  The amount of IFN-γ produced by Th2 
memory cells after one week of Th1-recall culture was calculated as a ration of mutant to 
wildtype.  Shown are the average ratios (±SEM) for cells recovered from nude recipients 
(left panel, four independent experiments), wildtype recipients (center panel, four 
independent experiments), or all recipients (right panel, 8 independent experiments).       
* p < 0.05, ** p < 0.01, *** p < 0.001.      
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Figure 3.9.  Intracellular cytokine staining of T-bet-deficient, STAT4-deficient, and 
wildtype Th2-derived memory cells.   Intracellular staining for cytokines was carried 
out at the time of harvest (Panel A) or after one week of Th1 or Th2 recall stimulation 
(B.)  FACS plots shown are gated for CD4
+
, DO11.10 TCR
+
 cells. 
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Stat4-deficient cells have normal T-bet induction and homeostatic expansion 
We then investigated potential mechanisms by which STAT4 could facilitate 
flexible IFN-γ production in memory Th2 cells undergoing a Th1 recall response.  
Previous studies have shown that STAT4 is required for the production of IFN-γ in a 
primary response by CD4
+
 T cells (Jacobson et al., 1995; Kaplan et al., 1996b; Zhang and 
Boothby, 2006).  Beyond this direct transactivation some studies have also shown that 
STAT4 is required for the maintenance of T-bet expression (Schulz et al., 2009; White et 
al., 2001), suggesting that any requirement for STAT4 may be due to its role in 
maintaining T-bet expression.  To test this, we carried out FACS staining for T-bet on 
Th1 effectors, and Th2 effectors under Th1 and Th2 recall responses from both wildtype 
and STAT4-deficinet backgrounds.  While we were able to reproduce the reported results 
that STAT4-deficiency results in an inability to maintain T-bet expression in effector Th1 
cells (White et al., 2001) (Fig. 3.10A, top panel), we found that at least half of donor-
derived cells expressed T-bet at a level comparable to Th1 effectors when cultured for 
one week under Th1 conditions (Fig. 3.10 ).  We therefore concluded that the 
requirement of STAT4 in the production of IFN-γ by memory Th2 cells is not due to an 
ability to regulate T-bet expression.    
Finally, since we are proposing a model in which homeostatic expansion dilutes 
out repressive CpG methylation, it is possible that the requirements for STAT4 and/or   
T-bet could arise from reduced cell division activity after transfer, resulting in a higher 
degree of methylation being retained.   Accordingly, we tested if the rates of division 
were slower for Tbx21 -/- or Stat4 -/- Th2 cells in recipient mice.  In vivo CFSE 
partitioning assays showed that there was no defect in rates of division for DO11.10 Th2 
cells that were T-bet- or STAT4-deficient cells compared to controls that were wildtype 
with respect to the transcription factors (Figure 3.10B).  To assay for possible defects 
longer after transfer, recipients of wildtype, Tbx21 -/-, or Stat4 -/- Th2 effectors were 
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pulsed with BrdU prior to harvest, and the incorporation of BrdU into genomic DNA was 
measured.  We found that the transferred cells had almost completely exited cell cycle 
and that the low rates of DNA synthesis were similar for all genotypes (Fig. 3.10C).  
Therefore, alterations in the number or frequency of cell divisions post transfer could not 
account for differences in plastic Ifng expression between wildtype and T-bet-deficient or 
STAT4-deficient samples. 
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Figure 3.10. T-bet induction and homeostatic expansion in STAT4-deficient Th2 
memory cells.   (A) T-bet expression was measured via FACS in WT and Stat4-/- Th1 
effector (top panel), recovered Th2 memory cells after one week of Th1 recall stimulation 
(middle panel), and recovered Th2 memory cells after one week of restimulation under 
Th2 conditions (bottom panel).  (B) Th2 effector cells from Wildtype, Tbx21-/-, and 
Stat4-/- DO11.10 mice were labeled with CFDA-SE and transferred into BALB/c nude 
recipients.  After two weeks, donor derived cells were analyzed for CFSE partitioning.  
The initial level of CFSE staining (dark outline) are shown for each cell type. (C) In vivo 
BrdU incorporation into Th2 effector cells from Wildtype, Tbx21-/-, and Stat4-/- 
DO11.10 mice five weeks post-transfer.  Recipient animals were injected with BrdU prior 
to harvest, and BrdU incorporation in donor derived cells was determined via FACS with 
an anti-BrdU antibody.    All events shown are gated on CD4
+
, DO11.10 TCR
+
 viable 
cells.   
  
83 
 
Alterations in CpG methylation in Tbx21-/- and Stat4 -/- Th2 effector and memory 
cells 
 Another possible mechanism that would account for the need for both STAT4 and 
T-bet in plastic Ifng expression would be that in the absence of these transcription factors, 
conditions in the effector phase of the T cell response would not allow for flexible 
cytokine production in the memory phase.  This could be in part due to increased 
maintenance of CpG methylation or from other epigenetic mechanisms.  To test this, 
DNA was extracted from Tbx21-/- and Stat4-/- effector Th2 cells after 11-12 days of Th2 
culture and CpG methylation of the Ifng promoter was analyzed as before (Figs. 2.3, 3.5).  
We found that there was little change in the methylation densities on the coding strands 
of T-bet or STAT4 deficient Th2 effectors (Fig. 3.11A).  Surprisingly, the non-coding 
strands of the transcription factor Th2 cells demonstrated a significantly higher degree of 
methylation across the assayed region of Ifng promoter (Fig.  311A).   As opposed to the 
wildtype effectors, Tbx21-/- and Stat4-/- Th2 effectors displayed symmetric CpG 
methylation of the Ifng promoter (Fig. 3.11B).    
 According to the model of cell-division driven passive demethylation we 
proposed, this symmetric methylation would be better maintained into the memory phase.  
To test this, we carried out methylation analysis of DNA from Tbx21-/- and Stat4-/- Th2 
memory cells.  As predicted by our model, we find that CpG methylation of both strands 
has been maintained, especially at the crucial -53CpG (Fig. 3.12).   This maintenance of 
repressive DNA methylation likely forms one of the several barriers to Ifng expression in 
T-bet or STAT4-deficient memory cells.         
  
84 
 
 
 
Figure 3.11. Symmetry of methylation in Tbx21-/- and Stat4-/- Th2 effector cells.   
Mean (±SEM) meCpG dinucleotides per clone are shown for Tbx21-/-, and Stat4-/- Th2 
effector cells as in previous figures. WT Th2 effector results from Fig. 2.3 are shown for 
comparison.  Clones from three independent experiments were analyzed for both coding 
and non-coding strands. (A) Comparison of symmetry of methylation in which the 
frequency of methylation on coding and non-coding strands from each sample are 
compared.  (B) Comparison of frequencies of methylation between WT, Tbx21-/-, and 
Stat4-/-.  (* p<0.05, ** p<0.01, *** p<0.001).    
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Figure 3.12.  Alterations in DNA methylation in Tbx21l-/- or Stat4 -/-  Th2 memory 
cells.  (A)  Mean (±SEM) meCpG dinucleotides per clone are shown for Tbx21-/-, and   
Stat4-/- Th2 effector cells as in previous figures. WT Th2 memory cell results from Fig. 
3.5 are shown for comparison. Clones from three independent experiments were analyzed 
for both coding and non-coding strands.  (B) The frequency of methylation at the -53CpG 
dinucleotide in memory Th2 cells is shown for coding and non-coding strands.  Results 
are from three independent experiments.  * p<0.05, ** p<0.01, *** p<0.001. 
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Figure 3.13. Symmetrical methylation inhibits passive demethylation.  Shown is a 
model of methylation status over the course of two cell divisions as per Fig. 3.6.   In the 
case of symmetrical methylation, dilution of CpG methylation would not occur. 
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Exogenous expression of T-bet in Tbx21-/- Th2 effector and Th2 memory cells 
 Having observed that deficiency of T-bet or STAT4 leads to an epigenetic 
environment antagonistic towards Ifng expression, we then wished to determine if 
restoring the expression of T-bet in polarized Th2 cells would allow for the production of 
IFN-γ by Th2-derived memory cells.   Previous studies have shown that ectopic 
expression of T-bet in fully polarized Th2 cells can lead to substantial IFN-γ production 
(Szabo et al., 2000, 2002) and that over-expression of T-bet can transactivate a fully 
methylated Ifng promoter (Tong et al., 2005).   A parallel study in human CD4
+
 T cells 
found that many Th2 cells would, under Th1 conditions, switch on their IFNG gene.  A 
subset of Th2 cells that could not be switched to IFN-γ producers was found, and  this 
subset was unable to upregulate T-bet under Th1 conditions (Messi et al., 2002).  Further 
studies showed that human CD4
+
 T cells lose the ability to express IFNG after several 
cycles of polarization, even when T-bet expression is driven by a retroviral vector 
(Sundrud et al., 2003).  However, no studies have touched on the effects of forcing T-bet 
expression in Tbx21 deficient Th2-derived memory cells.    
 To rescue T-bet expression in T-bet deficient Th2 effectors we used retroviral 
transduction with an MSCV-based retrovector with Thy1.1 as a bicistronic reporter 
(MSCV-IRES-Thy1.1 or MiT) carrying T-bet cDNA (MiT-T-bet).  After one cycle of 
Th2 differentiation, effector cells were restimulated and transduced with MiT-T-bet or an 
MiT vector lacking T-bet cDNA (MiT empty vector), and cultured under Th1 and Th2 
conditions for another week.  After a subsequent restimulation with APCs and antigen, 
intracellular staining for IL-4 and IFN-γ  revealed that T-bet expression forced IFN-γ 
expression in Tbx21 -/- Th2 cells (Figure 3.14)  This is consistent with previous work 
carried out in Th2 effector cells  (Szabo et al., 2000, 2002; Tong et al., 2005).  Thus we 
were able to reproduce previous results on the effects of exogenous T-bet expression in 
committed Th2 cells.  
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In parallel with the intracellular staining, MIT-T-bet transduced cells kept under 
Th2 conditions were transferred to recipient mice.  After three weeks, mice were 
harvested and cells were restimulated under Th1 and Th2 conditions (as per Fig. 3.3) 
followed by restimulation with antigen and APCs and intracellular staining (Fig.3.15).   
We found that donor-derived cells expressing Thy1.1 on their surface also were typically 
able to produce IFN-γ.  In contrast, non-transduced Thy1.1
-
 cells did not stain for IFN-γ, 
but did have a high frequency of   IL-4 positive cells.  Interestingly, culture under Th2 or 
neutral conditions did decrease the proportion of IFN-γ
+
 cells, suggesting that the forced 
expression of T-bet still benefits from IL-12 signaling found under Th1 conditions.  We 
therefore conclude that the expression of T-bet at a sufficient level can overcome the 
block to IFN-γ production seen in Tbx21-/- Th2-derived memory cells.  Based on these 
findings, we propose that multiple barriers to Ifng transcription are enacted during Th2 
differentiation, and that these barriers are reversed in wildtype Th2 cells as they become 
memory cells.                 
 
89 
 
 
Figure 3.14.  T-bet transduced Tbx21-/-  Th2 effectors produce IFN-γ.  Tbx21-/- 4get 
DO11.10 cells were cultured under Th2 conditions.  After four days,  GFP
+
 cells were 
collected and restimulated via antigen and APCs.  Two days after restimulation cells were 
underwent retroviral transduction with viruses derived from MiT-T-bet or an empty 
vector control.  Two days post-transduction cells were restimulated under Th1 or Th2 
conditions and cultured for one week.  ICCS was then carried out.  Events shown were 
gated on the viable (as determined by forward and side scatter) CD4
+ 
cells.  Data are 
representative of two experiments.   
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Figure 3.15. Production of IFN-γ by memory cells derived from T-bet transduced 
Tbx21-/- Th2 effector cells.  Tbx21-/- were transduced as in Fig. 3.14, and then 
restimulated under Th2 conditions.  After one week of culture, Th2 cells were transferred 
to nude mice.  Cells were recovered after four weeks and cultured under Th1, Th2, or 
neutral conditions for one week.  ICCS was then carried out.  Events shown are gated as 
per Fig. 3.14.  Results are representative of two independent experiments.
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Conclusions 
 We have found that the CpG methylation of the Ifng promoter established during 
Th2 effector development is not maintained into the memory phase in wildtype cells.  We 
have also demonstrated that STAT4 is required for the flexible production of IFN-γ.  
Furthermore we have provided evidence that the requirement for STAT4 is not due to a 
failure to induce T-bet during Th1 recall, and that neither T-bet nor STAT4 alter the rate 
of homeostatic cell division occurring after the effector phase.  Intriguingly, we have 
found that Th2 effectors deficient in STAT4 or T-bet have symmetrically methylated Ifng 
promoters, and that this methylation is retained in memory cells deficient for either 
transcription factor.  Taken together, these results suggest that T-bet and STAT4 serve to 
inhibit symmetrical methylation of the Ifng promoter, resulting in a hemimethylated state.  
Promoter hemimethylation is sufficient to inhibit CREB1 binding, but is not maintained 
through divisions occurring after the end of the effector phase.  The absence of repressive 
methylation alongside the induction of T-bet and activation of STAT4 in a Th1-biased 
recall response then allows for the flexible production of IFN-γ.   
In our work, we have also confirmed previous reports that STAT4 is required to 
maintain T-bet expression in effector Th1 cells, and that forced expression of T-bet can 
cause IFN-γ production, even from a fully committed Th2 cell. We have expanded this 
observation to show that forced T-bet expression in Th2-derived memory cells will also 
result in indiscriminate IFN-γ production.  
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IV. Discussion and future directions 
The capacity of Th2-derived memory cells to produce significant amounts of IFN-
γ when carrying out a recall response under Th1 conditions is an example of natural cell 
reprogramming.  Previous studies into lineage plasticity in CD4
+
 T cells demonstrated 
that IL-12, type I interferons, and T-bet are all required for transcription of Ifng by 
memory Th2 cells (Adeeku et al., 2008; Hegazy et al., 2010; Löhning et al., 2008), but 
little was understood about the molecular mechanisms that underlie this flexible cytokine 
expression.  Foundational work revealed that the Ifng promoter undergoes repressive 
CpG methylation (Fitzpatrick et al., 1998, 1999; Melvin et al., 1995; Winders et al., 
2004; Young et al., 1994), but it was unknown whether inhibitory DNA methylation is 
maintained in Th2-derived memory cells.  At the outset of this study, it was also unclear 
whether STAT4, crucial for IFN-γ expression in Th1 effectors (Jacobson et al., 1995; 
Morinobu et al., 2002; Zhang and Boothby, 2006), was required for flexible IFN-γ 
production.   In this work, we explored molecular mechanisms underlying cytokine 
production plasticity.  In undertaking this investigation, we have discovered a novel and 
functional epigenetic state of the Ifng promoter and further defined the transcription 
factor requirements for flexible expression of IFN-γ.     
In Th2 effector cells, we made the novel observation that the Ifng promoter 
exhibits asymmetric methylation in committed Th2 effectors.  The coding strand DNA 
preferentially acquires significantly increased methylation relative to the low frequency 
of meCpG in naïve CD4+ T cells and on the non-coding strand.  Furthermore, we have 
demonstrated that hemimethylation of the Ifng promoter was sufficient to alter protein-
DNA interactions and inhibit CREB1 binding at a highly conserved sequence required for 
promoter activity.  Consistent with this data, forced expression of CREB1 was able to 
transactivate a minimal Ifng promoter.  Using chromatin immunoprecipitation, we 
demonstrated that CREB1 preferentially bound to the Ifng promoter in Th1, but not Th2 
93 
 
effector cells.  This was the first report of the presence and inhibitory function of 
hemimethylation in lymphoid cells.  In Th2-derived memory cells we found a striking 
loss of methylation on the coding strand with overall CpG methylation densities similar 
to naïve CD4
+
 cells.  As methylation of the Ifng has been shown to have a strong 
repressive effect, these findings led us to infer that the loss of CpG methylation 
contributes to the flexibility of IFN-γ production.  In investigating the transcription factor 
requirements for the facultative production of IFN-γ, we found that the IL-12-induced 
factor STAT4 is required along with T-bet.  Surprisingly, Th2 effector cells deficient in 
T-bet or STAT4 had largely symmetric methylation of the Ifng promoter and memory 
cells derived from these effectors maintained promoter methylation.   Taken together, 
these data suggest that changes in the frequency of CpG methylation at the Ifng promoter 
is one part of the molecular mechanism underlying the reprogramming of gene 
expression in Th2-derived memory cells during a recall response.     
 While we have shown that the loss of methylation at the Ifng promoter is likely to 
be one mechanism underlying flexible gene expression, we do not contend that it is the 
only repressive mechanism.  We have shown that about 30% of Ifng promoter alleles 
from Th2 cells are unmethylated, and yet we see no IFN-γ production from this 
population.  Furthermore, in memory cells prior to recall stimulation, the Ifng promoter is 
unmethylated, but it requires several days of recall culture under Th1 conditions before 
cells begin to produce IFN-γ.  We therefore propose that other barriers to flexible 
expression of the Ifng gene exist, and that among these are the ability to up-regulate T-bet 
and achieve signaling through the IL-12 receptor.  
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Cells are flexible, genes are plastic 
The ability of memory Th2 cells to produce IFN-γ in a Th1 recall response is a 
rare example of fully differentiated somatic cells undergoing reprogramming without 
genetic or pharmacological manipulation.  This behavior has been termed both 
“plasticity” (Ahmadzadeh and Farber, 2002; Krawczyk et al., 2007; Sundrud et al., 2003) 
and “flexibility”  (Adeeku et al., 2008; Messi et al., 2002) within the literature, and both 
of these terms convey the needed information: a mature somatic cell takes on new 
functions when face with a new stimulus.  Plasticity however, carries meanings beyond 
what is truly happening in memory Th2 cells in that it often refers to the loss of previous 
cellular characteristics (Brockes and Kumar, 2002; Zhou and Melton, 2008a, 2008b). 
While this difference in terminology may seem subtle, the differences between the two 
terms are very significant in terms of ontogeny and functionality.  Plasticity carries with 
it the implication, not just of reprogramming, but also of a loss of the original function 
(Cobaleda and Busslinger, 2008).  We use the term flexibility to describe a lineage 
committed cell acquiring new programming without abandoning previous programing.  
Comparisons of the behavior of memory Th2 cells with instances of truly plastic behavior 
highlight the differences in the terms. 
Phenotypic plasticity in mammalian cells is most often seen in cell developmental 
processes where cells transition from a pluripotent state such as hematopoietic stem cells 
to a less plastic, more differentiated cell type (Askenasy et al., 2006; Rovó and Gratwohl, 
2008; Williams and Klinken, 1999).  In the absence of experimental manipulation, this is 
typically an irreversible process (Briggs and King, 1952; Waddington, 1957; Weismann, 
1893) involving alterations in multiple signaling pathways and gene expression 
(Abraham et al., 2013; Hu et al., 2012; Takahashi, 2012; Weissman et al., 2001; Zhou 
and Melton, 2008).  These changes during the process of differentiation also involve 
substantial modifications in the chromatin structures of target genes (Hawkins et al., 
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2010; Hu et al., 2012; Meissner, 2010; Zardo et al., 2008).  The stability of these 
epigenetic modifications allows for transient activity of lineage-determining transcription 
factors to have a lasting impact on gene expression in the absence of continued stimulus 
(Fletcher et al., 2002; Niller et al., 2011; Paschos and Allday, 2010).  The brevity of the 
stimulus which leads to the epigenetic changes has led many to describe this mechanism 
as a “hit and run” (Fletcher et al., 2002; Niller et al., 2011).  The establishment of these 
epigenetic landscapes serves to continually reinforce a cell’s identity and provides a 
substantial obstacle to true plasticity in mature somatic cells (Boheler, 2009; Conrad Hal 
Waddington, 1957; Papp and Plath, 2011; Takahashi, 2012; Zhou and Melton, 2008).   
 
Phenotypic plasticity and cancer 
One regretfully common instance of a non-stem cell attaining plasticity is in the 
pathogenesis of cancer.  While cancer cells often retain some features of their original 
lineage such as surface molecules, the functionality of the cells has been lost in the 
transition to a neoplastic state.  A very striking example of plasticity underlies the process 
of cancer metastasis. During metastasis, epithelial-like tumor cells transition to a 
mesenchymal state to leave the primary tumor (Thiery, 2002; Thiery et al., 2009).  The 
epithelial to mesenchymal transition (ETM) in cancer is thought to occur stochastically as 
genetic aberrations in cancer cells lead to the loss of epithelial cell traits (Craene and 
Berx, 2013; Rangel et al., 2012; Thiery, 2002).  Unlike differentiation in non-cancerous 
cells, this transition can be reversed, allowing mesenchymal cancer cells to transition 
back to epithelium and establish new solid tumors (Craene and Berx, 2013; Marjanovic et 
al., 2013; Strauss et al., 2012).   
Stem cell populations share several other characteristics with cancer cells beyond 
phenotypic plasticity (Strauss et al., 2012).  One important cancer trait shared by stem 
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cells is a rapid cell cycle lacking checkpoints in the G1 phase (Boheler, 2009; Kapinas et 
al., 2013).  One reason for this shared trait may be the centrality of the c-Myc pathway to 
both cancer and embryonic stem cell programing (Kim et al., 2010; Takahashi et al., 
2007).  While central to many cell processes, c-Myc is a potent oncogene (Ischenko et al., 
2013; Kim et al., 2010; Poe et al., 2012), and murine recipients of stem cells generated by 
using transgenic Myc have an increased incidence of tumor formation (Okita et al., 
2007).  Both embryonic stem cells and cancer cells also show wide variations in 
epigenetic modifications across populations, suggesting a state of epigenetic instability 
(Humpherys et al., 2001; Marjanovic et al., 2013; Meshorer et al., 2006). The similarities 
between cancer cells and stem cells do, in part, arise from shared pathways and possibly 
similar epigenetic states.  
Induction of plasticity: Transdifferentiation and dedifferentiation 
While there is little evidence for healthy somatic cells to display plasticity in 
nature, much work has centered on experimental manipulations that reprogram 
differentiated cells (reviewed in Gurdon and Melton, 2008).  Early work in amphibians 
found that the transfer of a nucleus from a more developed cell to a enucleated oocyte 
would allow the fused oocyte to develop into an embryo, albeit at a relatively low 
frequency (Briggs and King, 1952; Gurdon, 1962; Gurdon et al., 1975).  From these 
experiments, it was learned that differentiated cells retain the necessary genetic 
information, but usually not the developmental potential of embryonic stem cell.  This 
incomplete plasticity is due in large part to epigenetic conditions established as a cell 
progresses towards a less pluripotent state.  Often referred to as “Waddington’s 
epigenetic landscape,” the chromatin modifications enacted upon differentiation serve to 
prevent lineage plasticity under normal conditions, and any reprogramming strategy must 
overcome this barrier (Davis and Eddy, 2013; Ladewig et al., 2013; Takahashi, 2012; 
Zhou and Melton, 2008). 
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One way to achieve phenotypic plasticity is to prevent other fates from being 
foreclosed upon.  A seminal example of plasticity of this variety is the loss of B cell 
identity in pro-B cells lacking the Pax5 gene (Nutt et al., 1999).   These Pax5-/- pro-B 
cells express some B cell lineage markers and undergo some rearrangement of the         
Ig-heavy chain locus, but their development does not progress to mature B cells  (Nutt et 
al., 1998).  After in vitro culture with cytokines other than IL-7, Pax5-/- cells lost 
characteristics of the B lineage and gained the phenotype and function of one of several 
other cell populations such as NK cells, Macrophages, and T cells (Cobaleda and 
Busslinger, 2008; Nutt et al., 1999).  When transferred into Rag-/- deficient mice, these 
Pax5-/- pro-B cells were able to generate a long-term T cell population (Rolink et al., 
1999).  This finding demonstrates that, in the absence of Pax5, pro-B cells maintain the 
plasticity and self-renewing capabilities of hematopoietic stem cells even after appearing 
to commit to the B cell fate. 
Alongside the removal of transcription factors which promote a distinct lineage, 
plasticity can also be induced by the exogenous expression of transcription factors linked 
to a cell population in a process termed transdifferentiation  (Cobaleda and Busslinger, 
2008).  Pancreatic exocrine cells have been reprogrammed into insulin-producing cells 
almost entirely identical to pancreatic β cells via the forced expression of three 
transcription factors that drive β cell development:  Mafa, Ngn3, and Pdx1  (Zhou et al., 
2008).  This method has been shown to directly reprogram cells to the endocrine cell fate 
without regression to a pluripotent progenitor state.  Likewise, the introduction of 
lineage-specifying transcription factors has been able to convert fibroblast to neurons 
(Vierbuchen et al., 2010) and cardiomyocytes (Ieda et al., 2010).  In all of these settings 
the gain of a new lineage-defined function is coupled to the loss of the characteristics of 
the original lineage.         
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Perhaps the most striking instance of induced plasticity is in the generation of 
pluripotent cells from somatic cells in a process termed dedifferentiation (Cobaleda and 
Busslinger, 2008).  These iPSs (induced pluripotent stem cells) were first created by 
retroviral introduction of the transcription factors Oct3/4, Sox2, Klf4, and c-Myc into a 
fibroblast (Takahashi and Yamanaka, 2006; Takahashi et al., 2007).  Later, the process 
was altered to exclude c-Myc to avoid tumor formation (Nakagawa et al., 2008; Okita et 
al., 2007).  Further experiments have used progenitor cells derived from iPS cells to 
correct genetic conditions in mouse models of sickle cell anemia (Hanna et al., 2007) and 
hemophilia (Xu et al., 2009).  The ability to dedifferentiate somatic cells and 
subsequently redifferentiate them along a desired line is a prime example of plasticity.  
 While Th2-derived memory cells do lose certain aspects of the Th2 gene-
expression program, they do not fully revert to a plastic state.  That the commitment to 
produce IL-4 is maintained even in a Th1 recall response (Adeeku et al., 2008; Hegazy et 
al., 2010; Krawczyk et al., 2007; Löhning et al., 2008) suggest not a complete loss of 
effector programming (as would be entailed by plasticity), but rather a modification of 
the existing effector program.  Therefore it is our contention that these cells are exhibit a 
functional and transcriptional flexibility rather than true plasticity.  That being said, a 
case can be made that the Ifng gene does exhibit plasticity, at least pertaining to CpG 
methylation, as DNA from memory Th2 cells has almost identical Ifng promoter 
methylation to that found in naïve CD4
+
 T cells.  In summary, genes associated with an 
effector program may be plastic, but the memory cells themselves adapt existing 
programing in response to stimuli during recall responses.   
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An extra layer of adaptability: Why might this reprograming exist? 
 The exact effector program a CD4
+
 T cell executes  upon recognizing its cognate 
antigen is mostly determined by signals other than the peptide antigen (Abbas et al., 
1996; Kaplan and Grusby, 1998).  This in turn entails that the effector program adopted is 
not so much dependent on the nature of the pathogen, but rather the local cytokine milieu 
at the time of TCR-pMHC engagement.  While the local cytokine milieu typically reflects 
the response needed to clear a given pathogen, there are exceptions.  In foundational 
immunologic research in mice, it was found that some mice strains readily cleared an 
infection of Leishmania major while other strains developed chronic infections  (Heinzel, 
1989; Liew, 1989; Scott et al., 1988).  Resolution of leishmaniasis requires IFN-γ 
secretion by Th1 effector cells  (Carl et al., 1993).  In susceptible mice, an initial burst of 
IL-4 in the local environment occurs at the time of exposure.  This in turn prevents Th1 
polarization and effective clearance of Leishmania (Aseffa et al., 2002; Himmelrich et al., 
1998; Launois et al., 1995).  Given that exposure to IL-4 during initial T cell activation 
can preclude the formation of a protective immune response, a mechanism by which Th2-
derived memory cells could acquire the capacity to produce IFN-γ provides an additional 
layer of adaptability in the T helper response.   
 In terms of human health, consideration of the developing world also can lead to 
an appreciation for the need for flexible IFN-γ production.  Infections by parasitic worms 
have been common throughout much of our evolutionary history and remain endemic 
developing regions of the world (Crump et al., 2012; Dold and Holland, 2011; Gryseels, 
2012; Neghina et al., 2012).  As discussed previously, helminthes drive robust Th2 
responses leading to the production of IL-4 (Abbas et al., 1996; Svetic et al., 1993).   
Many pathogens common in the developing world such as mycobacteria or plasmodia 
also require a Th1 response for effective control (Green et al., 2013; Orme et al., 1993), 
and the presence of IL-4 from a Th2 response to parasitic worms could theoretically 
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prevent the development of an appropriate Th1 response.  Studies have found significant 
rates of co-infection between pathogenic worms and intracellular parasites occurring in 
multiple countries (Abate et al., 2012; Borkow et al., 2001; Rafi et al., 2012; Tristão-Sá et 
al., 2002)  In some cases, parasitic worm infections have been found to exacerbate TB in 
human patients (Borkow et al., 2001; Elias et al., 2001, 2006; Potian et al., 2011; Resende 
Co et al., 2007; Stewart et al., 1999; Tristão-Sá et al., 2002) and decrease Th1 responses 
in cases of lepromatous leprosy (Diniz et al., 2010; Prost et al., 1979).  While there is 
strong correlative data spanning decades and multiple human populations, co-infection 
experiments using cotton rats as a model showed little to no effect of either nematode or 
helminth infection on the progression of tuberculosis (Hübner et al., 2012).  While these 
data appear contradictory, it may indicate that variables such as parasite load, order of 
infection, host species, and exact species of parasite have a bearing on the relationship 
between worm infection and the response to mycobacterium (Rafi et al., 2012).  The 
ability of a mycobacterium-reactive Th2-derived memory cell to produce IFN-γ during a 
recall response in the absence of Th2-skewing parasites could provide some measure of 
prophylaxis against reinfection.             
 
 Another reason why Th2 memory cells might have developed plastic Ifng 
expression is the difference in the magnitude between loss of IFN-γ signaling and the loss 
of IL-4 signaling.  Loss of IFN-γ signaling or production in humans results in many 
clinically significant and life threatening issues (Glosli et al., 2008; Vinh et al., 2009).  
The loss of IL-4 production by Th2 cells is less likely to cause significant medical issues 
aside from a higher predisposition to inflammation and difficulty clearing infections of 
parasitic worms and is less likely to affect long-term survival (Brewer et al., 1996; 
Hultgren et al., 1998; Jankovic et al., 1999; Kopf et al., 1993; Pearce et al., 1996; Tissi et 
al., 2009).  Therefore, having a mechanism for Th2 memory cells to acquire IFN-γ 
production capabilities could allow these cells to provide a response to acutely lethal 
pathogens.       
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 A final reason for flexibility might be found in the nature of antigen recognition.  
T cells recognize peptide antigens which could be derived from any number of 
exogenous sources.  A clone which recognizes a peptide that is highly conserved between 
different pathogens could experience stimulation under a variety of polarizing conditions.    
 
DNA methylation, cytokine expression, and memory 
 Early work in IFN-γ and IL-4 producing CD4
+
 T cell clones identified differential 
DNA methylation of the Ifng promoter as a possible mechanism for regulation of IFN-γ 
production (Melvin et al., 1995; White et al., 2006; Winders et al., 2004; Young et al., 
1994).  Expression of the primary de novo DNA methyltransferase in T cells: DNMT3a, 
is upregulated following stimulation via the TCR (Gamper et al., 2009) , and it has been 
shown to be vital in the prevention of inappropriate cytokine expression in T helper 
responses (Gamper et al., 2009; Thomas et al., 2012).   The symmetry enforcing 
methyltransferase DNMT1 has also been shown to be vital in repressing the expression of 
Th2 cytokines during a Th1 effector response (Lee et al., 2001; Makar and Wilson, 
2004).  These past studies have indicated that the DNA methylation of cytokine genes is a 
crucial feature of the transition from a naive CD4
+
 T cell to an effector.      
 Typically, CpG methylation is highly symmetrical, with CpGs on both the coding 
and non-coding strand having the same methylation frequency (Ehrlich and Wang, 1981).  
These symmetrically methylated dinucleotide pairs would, upon cell division, give rise to 
hemimethylated daughter strands.  In late S phase, DNMT1 is recruited to sites of 
hemimethylation where it then enforces symmetry (Bashtrykov et al., 2012; Tatematsu et 
al., 2000), allowing CpG methylation to be a heritable, and potentially permanent,  
repressive epigenetic modification (Bender et al., 1999; Deaton and Bird, 2011).   
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 The inhibitory effects of symmetrical CpG methylation on gene expression both 
directly in a site-specific manner (Jones and Chen, 2006; Sunahori et al., 2009) and 
indirectly via the recruitment of transcription factors with a methyl-binding domain (Bird 
and Wolffe, 1999; Dhasarathy and Wade, 2008; Hendrich and Bird, 1998)  have been 
studied in great detail, but little was known about the functionality of asymmetric 
methylation.  In DNA synthesis, hemimethylated daughter chromosomes are created, but 
the action of DNMT1 quickly reinforces symmetry (Tatematsu et al., 2000).            
Strand-biased asymmetric methylation has previously been described in cancer cells 
(Ehrlich and Lacey, 2013; Jain et al., 2011; Shao et al., 2009) but has not been reported in 
normal, non-cycling somatic cells prior to this work.        
While losses of DNA methylation have been reported in T cells (Kersh et al., 
2006; Lee et al., 2002; Makar and Wilson, 2004; Makar et al., 2003), direct evidence for 
DNA demthylases has only recently been published (Kangaspeska et al., 2008; Métivier 
et al., 2008).  Prior to these findings the existence of active DNA demethylases was 
suspected but unverified.  The exact mechanisms underlying DNA demethylation are still 
an active field of research, and are known to involve members of the ten-eleven 
translocation (TET) and AID/APOBEC enzyme families (Arioka et al., 2012; Bhutani et 
al., 2010; Guo et al., 2011; Ito et al., 2010; Tahiliani et al., 2009) as well as base excision 
repair glycosylases (Cortellino et al., 2011; Hashimoto et al., 2012a; He et al., 2011).  
The process of active demethylation mediated by TET enzymes starts with the conversion 
of 5-methyl cytosine (5mC) into 5-hydroxymethyl cytosine (5hmC) (Bhutani et al., 2011; 
Guo et al., 2011; Ito et al., 2010) eventually leading to base excision repair enzymes 
swapping out the modified methyl-cytosine for an unmethylated cytosine (Bhutani et al., 
2011; He et al., 2011).  AID/APOBEC has been shown to deaminate me-C to thymidine, 
which is then replaced via DNA repair mechanisms (Cortellino et al., 2011; Hashimoto et 
al., 2012a).     
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The functional difference between hydroxymethyl cytosine and methyl cytosine 
extends beyond active demethylation by base pair excision.  The preferential 
demethylation of the paternal genome in zygotes has been found to be preceded by a 
conversion of methyl cytosine to hydroxymethy cytosine on paternal, but not maternal 
genetic information (Inoue and Zhang, 2011).  Furthermore, loss of 5hmc was found to 
be replication dependent, suggesting a passive demethylation process (Inoue and Zhang, 
2011) similar to the one we are proposing.   Evidence that 5hmC might favor passive 
demethylation via promoting asymmetry has also been reported.  Hydroxymethylated 
cytosine has been shown to inhibit DNMT1’s activity leading to an unmethylated 
daughter strand (Chen et al., 2012; Hashimoto et al., 2012b; Valinluck and Sowers, 
2007).  Therefore, the TET enzymes may be central both to some mechanisms of active 
and passive demethylation.    
Interestingly, recent work has shown that there is a global decrease in methylation 
in CD4
+
 memory cells, as well as expression of DNA methyltransferases (Hashimoto et 
al., 2013; Li et al., 2012).   The decrease both in methylation and the enzymatic 
machinery needed to maintain it across generations has implications for the plasticity of 
cytokine genes in T helper memory.  In short, less DNMT1 in the cell could translate to 
decreased maintenance of methylation during cell division, which could in turn hasten the 
passive loss of CpG methylation from cytokine genes. 
 
Future directions: flexible IFN-γ production and the antibody response 
While the production of IFN-γ by Th2-derrived memory cells is well established 
(Adeeku et al., 2008; Hegazy et al., 2010; Krawczyk et al., 2007; Löhning et al., 2008), 
the extent to which it can influence an actually immune response has never truly been 
investigated.  One major effect of the Th1 effector program is to guide B cells into class 
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switch recombination to the IgG2a antibody subtype (Brewer et al., 1996; Snapper and 
Paul, 1987).  Individuals lacking the ability to make IgG2 subtypes are significantly more 
susceptible to certain bacterial infections, especially in the respiratory tract (Jefferis and 
Kumararatne, 1990; Oxelius, 2008; Preud’homme and Hanson, 1990).  Research on the 
functional significance of IgG2a have revealed that it is the most efficient IgG subtype at 
opsonization in response to capsular antigens (Oishi et al., 2013; Schlageter and Kozel, 
1990).  It has also been shown to be the most effective subtype in conferring protection to 
lymphocytic choriomeningitis virus whereas IgG1 antibodies against the same epitopes 
failed to provide protection (Baldridge and Buchmeier, 1992).  The increased activity of 
IgG2a is thought to stem from its ability to bind its phagocytes-expressed Fc receptor, 
FcγRIV, with a 40-fold higher affinity than IgG1 can bind FcγRIII, its activating Fc 
receptor (Bolland, 2005; Nimmerjahn and Ravetch, 2006; Nimmerjahn et al., 2005).  This 
increased binding affinity to the Fc receptor allows IgG2a to effectively opsonize 
antigens at a lower concentration.   In order to test the physiological significance of IFN-γ 
productions, we have designed experiments to test the ability of a memory Th2 
population to induce an IgG2 response when given a recall challenge in vivo under     
Th1-skewing conditions.    
The experimental methodology (summarized in Fig. 4.1) was in short to 
immunize mice with KLH (keyhole limpet hemocyanin) coupled with nitrophenol (NP) 
as a hapten.  The initial immunization was carried out in the Th2-response promoting 
adjuvant alum (Grun and Maurer, 1989).  After two weeks the recipients were boosted 
with NP-KLH.  After two weeks, wildtype or Tbx21-/- GFP
+
 4get DO11.10 Th2 effectors 
were transferred into immunized mice, with some immunized mice not receiving Th2 
cells as a control.  After six weeks, mice were given a recall challenge of NP-Ovalbumin 
in complete Freund’s adjuvant (CFA).  The carrier switch to ovalbumin allows us to 
introduce an antigen to which the endogenous T cells will have had no exposure to while 
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providing the donor-derived DO11.10 cells with their cognate antigen.  We bled mice 
before the recall challenge, one week post-recall, and two weeks post recall.  Serum was 
analyzed for NP-specific IgG2a content and the effect of recall stimulation was calculated 
by subtracting the pre-recall value from the post-recall values.  In the pilot experiment, 
we did see in increase in NP-specific IgG2a in the recipients of WT Th2, but not T-bet 
deficient Th2 cells or in the immunized mice that did not receive Th2 effectors (Fig. 4.2).  
This preliminary result suggests that Th2 memory cells can influence B cells to class 
switch to IgG2a producers.  If this result is reproducible, it will be the first confirmation 
of the physiological relevance of flexible IFN-γ production.   
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Figure 4.1. Timelineof antibody class switching experiment.  Shown is a schematic for 
the experiment designed to test whether IFN-γ produced by Th2-derived memory cells 
can generate an IgG2a antibody response   
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Figure 4.2. Changes in NP-specific IgG2a one week after recall.  Serum samples 
acquired one week after recall stimulation and samples immediately prior to recall 
stimulation were analyzed via ELISA for NP-specific IgG2a.  Shown is the mean 
difference in IgG2a concentration as determined by subtracting the pre-recall OD450 
from the one week post recall OD450.  Error bars represent one standard deviation.  For 
recipients of WT or T-bet KO Th2 effectors, N=2.  The sample which did not receive Th2 
effectors is N=1.    
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Future directions: methylation Vs. hydroxymethylation 
A second exiting direction that this project could take is to determine if the 
methylation at the Ifng promoter is actually hydroxymethylation.  As discussed above, 
hydroxymethylation does not activate DNMT1, making it a likely candidate for a 
mechanism underlying hemimethylation.  An alternative hypothesis is that the 
recruitment of DNMT1 to the Ifng is blocked during Th2 polarization, resulting in a true 
hemimethylated state. 
 Along this vein, if hydroxylmethylation of the Ifng promoter is detected in Th2 
cells, two further questions suggest themselves: By what mechanism is 
hydroxymethylation established, and when is the methyl-cytosine (mC) converted to a 
hydroxymethly-cytosine (hmC)?   The resolution of the first question would likely center 
on the TET family of enzymes, as they have been shown to carry out this conversion in 
several systems.  Detection of TET proteins at the Ifng promoter in Th2 cells would 
suggest their involvement in establishing the asymmetrical methylation in Th2 effectors.   
The second question centers more on what stimuli would promote hydroxymethylation.  I 
have considered two models which would fit with our current understanding of T helper 
cell differentiation and the regulation of Ifng expression. 
 In the first model, enzymes to modify mC into hmC would be recruited to the Ifng 
promoter early in Th2 differentiation, and possibly at the same time as DNMT3a, 
meaning that there would be little time in which actual mC would be present at the Ifng 
promoter.  In the second model, enzymes catalyzing the mC to hmC conversion would 
arrive at the Ifng promoter as signaling from the TCR and the IL-4 receptor was lessened 
later in the Th2 response, meaning that hmC would only be detected at later timepoints. 
 A third possibility is that hydroxymethyl is directly added to CpGs at the Ifng 
promoter.  As no enzyme has been shown to catalyze this reaction, and evidence suggests 
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that DNMT3s would not be capable to carrying this reaction out (Chen et al., 2012), I 
find this to be the least likely of the explanations.   
 The determination of if, when, and how methyl-cytosines on the Ifng promoter are 
converted to hydroxymethy-cytosines would increase our understanding of the 
mechinisms facilitating the creation of a unstable epigenetic modification.   
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V. MATERIALS AND METHODS 
 
Mice BALB/c Il4-IRES-Gfp (“4get”), DO11.10 mice were bred with BALB/c Tbx21 
(T-bet) -/- (KO) or BALB/c Stat4 KO mice (Jackson labs). BALB/c-ByJ (Jackson labs) 
and athymic BALB/c nude (Foxn1/Foxn1) mice were used as recipients for transfer 
experiments. Recipients were 4-6 weeks old at the time of transfer.  Mice were 
maintained in micro-isolator cages at a Vanderbilt University facility in accordance with 
Institutional Animal Care and Use Committee guidelines and an approved protocol.       
 
Reagents Fluorophore-conjugated and purified mAb were obtained from BD 
Pharmingen (San Jose, CA) and purified recombinant cytokines from Leinco (St. Louis, 
MO) unless otherwise indicated. Purified 11B11 anti-IL-4 and recombinant huIL-2 were 
obtained from the Biological Response Modifiers Program (NCI, Frederick MD).  Anti-
T-bet-eFluor 660 was obtained from eBioscience (San Diego, CA).  Oligonucleotides 
were synthesized by Invitrogen (Grand Island, NY) unless otherwise stated.   
 
Cell culture and purification of GFP
+
 IL-4 producing effectors and adoptive 
transfers DO11.10 cells were activated with OVA323-339 peptide, and all cells 
were cultured, as described (Adeeku et al., 2008) with the following modifications.  For 
Th1 culture conditions, cells were plated at 7 x 10
6
 cells/ml and received 1 µg/ml OVA 
peptide, 5 ng/ml IL-12, and 3 µg/ml anti-IL-4 antibody 11B11.   For Th2 cell cultures, 
cells were plated at 3.5 x 10
6
 cells/ml and received 0.5 µg/ml OVA peptide, 7.5 ng/ml IL-
4, 3 µg/ml anti-IFN-γ antibody, and 2 µg/ml anti-IL-12 antibody.  Both Th1 and Th2 cell 
cultures were supplemented with IL-2 (50 units/ml 24 and 72 hours after Ag stimulation). 
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GFP
+
 Th2 effector cells were purified for transfer as described (Adeeku et al., 2008). 
After four days of culture in Th2 conditions, 4get, DO11.10 cells (Tbx21 -/-, Stat4 -/-, or 
transcriptionally WT) were stained with APC-conjugated anti-CD4 and PE-conjugated 
KJ1-26 (anti-DO11.10 TCR) antibodies and flow sorted on a FACS Aria (BD, Franklin 
Lakes, NJ) to purify (> 98.5%) viable DO11.10 KJ1-26
+ 
CD4
+
, GFP
+
 cells. Prior to 
transfer or DNA isolation for methyl-CpG analyses, these cells were cultured in Th2 
conditions for 9-10 d after re-stimulation with APCs (4:1 with T cells) and 0.25 µg/ml 
OVA323-339 (13-14 d total).    
 
Quantitation of cytokine production T helper cell cultures plated with APCs at a 
1:4 ratio, and single-cell suspensions of recipient spleens, were stimulated with 1 µg/ml 
OVA323-339. Cytokine concentrations in supernatant collected after 36 hr were quantified 
using a flow cytometric kit (Th1/Th2/Th17 cytokine bead array; BD Pharmingen). 
Intracellular cytokines were analyzed by stimulating cells 18 hr with OVA323-339 (1 
µg/ml) in the presence of APCs, followed by Golgi-Stop (BD) (2-3 hr), and staining in 
the presence of anti-CD16/32 (Fc Block, BD Pharmingen) as previously described 
(Adeeku et al., 2008).  Viable cells were selected based on forward and side scatter 
characteristics, and fluorescence signals representing intracellular cytokines were 
determined in cells positive for the DO11.10 TCR and CD4.  
 
Bisulfite analysis of DNA methylation DNA isolated from flow-purified naïve, 
effector (Th1, Th2, 13 d) and memory CD4 T cells, or from tissues, was digested with 
Bam H1 (New England Biolabs, Ipswich MA), bisulfite-modified using the Imprint 
bisulfite modifying kit (Sigma-Aldrich, St. Louis, MO), then used as template in 
quadruplicate PCR performed using primer pairs specific for each modified strand 
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sequence in the Ifng promoter (Table 5.1)  (Jones and Chen, 2006). The noncoding strand 
of the Ifng promoter was amplified with a single reaction, while the coding strand was 
amplified using a nested PCR. After pooling four tubes of separate amplification for each 
sample, specific PCR products were identified on agarose gels, extracted using the 
Qiaquick gel extraction kit (Qiagen, Valencia, CA), ligated with T-easy vector (Promega, 
Madison, WI), and then transformed into JM109 cells (Agilent, Santa Clara, CA).  For 
each of three independent biological replicate cell samples and for each strand, eight to 
ten clones derived from each reaction pool were sequenced and scored for the frequency 
of unmodified C residues in the CpG dinucleotides; the modification frequency for C 
residues outside of CpG dyads was verified as > 99% for all sample sets.   
 
EMSA      EMSAs were performed as reported (Jones and Chen, 2006; Lee et al., 2010) 
except that extracts of Th1 cells developing from primary mouse CD4
+
 T cells were used. 
Methylated upper strand oligonucleotides were synthesized by Invitrogen (Grand Island, 
NY). The upper strand oligonucleotides were designated as unmethylated, meC(-53) 
hemimethylated, and tri-hemimethylated (meC at -53, -45, and -34) (Table 5.1). Each 
was annealed to an unmethylated lower strand oligonucleotide after radiolabeling with γ-
[32P]-ATP (Perkin-Elmer, Waltham MA) and T4 polynucleotide kinase (New England 
Biolabs, Beverly MA). For competition assays, unlabeled competitor was added 
simultaneously with the labeled probe at molar ratios (competitor:probe) of 100, 10, and 
1:1.  Antibodies used for the super shift assays were CREB1 (sc-186), ATF2 (sc-187) and 
c-Jun (sc-45) (Santa Cruz Biotechnology, Santa Cruz, CA). 
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Table 5.1.  Sequences of oligonucleotides. 
 
Oligonucleotide Sequence  Purpose  
Bisulfite coding strand, Outer sense  GAA-ATT-TAT-ATT-ATA-AGG-GTA-AAA-AGG-GGG PCR primer 
Bisulfite coding strand, Outer anti-sense CAA-ACT-TTC-TAA-ACT-TTC-AAT-AAC-TAT-AC PCR primer 
Bisulfite coding strand, Inner sense  TAG-AGA-ATT-TTA-TAA-GAA-TGG-TAT-AGG-TGG-GTA-T PCR primer 
Bisulfite coding strand Inner anti-sense CCA-TAA-AAA-AAA-ACT-ACA-AAA-CCA-AAA-TAC-AAT-A PCR primer 
Bisulfite non-coding strand, Outer sense GTT-ATG-AGG-AAG-AGT-TGT-AAA-GTT-AAG-ATG-TAG PCR primer 
Bisulfite non-coding strand, Outer anti-sense CCC-AAC-CAC-AAA-CAA-AAA-CTC-CCT-ATA-CTA-TAC PCR primer 
Bisulfite non-coding strand, Inner sense  TAG-GAG-GAG-AAG-TTT-AGA-ATT-TTT-GTT-TTA-AGT-T PCR primer 
Bisulfite non-coding strand, Inner anti-sense ACA-ATT-TCC-AAC-CCC-CAC-CCC-AAA-TAA-TAT-AAA-A PCR primer 
Ifng promoter sense CGG-GGC-TGT-CTC-ATC-GTC PCR primer 
Ifng promoter anti-sense CTC-GGG-ATT-ACG-TAT-TTT-CAC-AA PCR primer 
Coding strand, Un GTG-AAA-ATA-CGT-AAT-CCC-GAG-GAG-CCT-TCG-A  EMSA probe 
Coding strand, 1XME GTG-AAA-ATA-(Me)CGT-AAT-CCC-GAG-GAG-CCT-TCG-A EMSA probe 
Coding strand, 3xME GTG-AAA-ATA-(Me)CGT-AAT-CC-(Me)C-GAG-GAG-CCT-T-(Me)CG-A EMSA probe 
Non-coding strand TCG-AAG-GCT-CCT-CGG-GAT-TAC-GTA-TTT-TCA-C EMSA probe 
 
Table 5.1. Sequences of oligonucleotides.  Shown are all PCR primers and EMSA 
probes used in this work.  Methylated cytosines are denoted as (Me)C.  
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Transient transfection and reporter assays  Nucleofection was carried 
out via the Amaxa T cell kit (Lonza, Basel, Switzerland) using a minimal Ifng promoter 
reporter P1P2-Luc (Soutto et al., 2002) along with pCMV-Sport6-CREB1 or  pCMV-
Sport6.  All results were normalized to GFP expression from the pMAX-GFP plasmid 
(Lonza) measured via flow cytometry. Luciferase activity was measured using the Dual-
glow luciferase assay system (Promega) according to manufacturer’s protocols.     
 
Chromatin Immune Precipitation assays Chromatin immunoprecipitation (ChIP) 
assays were performed essentially as described previously (Zhang and Boothby, 2006).  
In brief, 10x10
6
 cells were suspended in IMDM supplemented with 10% FBS.  
Formaldehyde was added to a total concentration of 1%, and crosslinking was carried out 
on ice for 20 minutes.  The crosslinking reaction was quenched by the addition of excess 
glycine, and the cells were washed in PBS.  Cells were then resuspended in lysis buffer 
(50mM Tris, 10mM EDTA, 1% SDS, pH8) and sonicated in a Bioruptor (Diagenode, 
Denville, NJ) to produce an average sheered DNA length of 400 bp. Immune 
precipitation was carried out on one million cell equivalents using 1ug anti-AcH3(K9) 
(Millipore, #DAM1813175), or CREB1 (Santa-Cruz, sc-186X), and the precipitates were 
analyzed by PCR using primers shown in Supplemental Table I.  Quantification of PCR 
products was carried out via southern blotting and phosphor imaging.    
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Figure 5.1.  Workflow for chromatin immunoprecipitation (ChIP) assay.  (A) 
Chromatin is isolated from formaldehyde cross-linked cells.  (B)  The chromatin is 
sonicated or otherwise sheared to approximately 400bp segments.  (C).  Antibodies 
against a transcription factor or modified histone and protein-A sepharose beads are used 
to precipitate a target protein and associated DNA.  (D) Protease digestion and ethanol 
precipitation leaves only purified DNA that was bound to the target protein.  Analysis via 
PCR can now begin. 
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Proliferation in vitro and in vivo  Proliferation studies using CFSE partitioning and 
BrdU incorporation were carried out as described (Lee et al., 2010).  For CFSE 
partitioning in vivo, Th2 cells were grown for five days, labeled with CFDA-SE 
(Invitrogen) (2.5µM, 15 min) following manufacturer instructions, and then transferred 
into BALB/c recipients. Fluorescence was measured on donor-derived cells recovered 12 
d after transfer with gating as described above. For CFSE partitioning assays in vitro, 
DO11.10 splenocytes were either labeled, Ag-stimulated, and cultured 2 d, or activated 
with Ag, cultured in Th2 conditions (11 d, with one interim Ag stimulation as for cells 
used in adoptive transfers), labeled with CFDA-SE as above, and then cultured 2 d in IL-
2 supplemented medium before analysis by flow cytometry. For assays of BrdU 
incorporation into donor cells in vivo, recipient mice were injected twice (72, 24 h before 
harvest; 3 mg i.p. per injection) with BrdU (Sigma Aldrich) in sterile saline. Cells 
harvested 12 d post-transfer were then processed as described (Lee et al., 2010) to detect 
Alexa-647 anti-BrdU (Invitrogen) in donor- (KJ1-26
+
) and recipient-derived CD4
+
 T 
cells by flow cytometry.  For in vitro assays, BrdU (1 µM) was added to Th2 cultures 
(days 2 and 13 after Ag activation) followed 4 h later by processing, direct 
immunofluorescent anti-BrdU staining, and flow cytometry of KJ1-26
+
 CD4
+
 cells.                
   
Retroviral transduction  Retroviral transduction was carried out using as previously 
described (Zhang and Boothby, 2006).  In brief, retrovirus-containing supernatants from 
ΦNX packaging cells transfected with MSCV-IRES-Thy1.1 (MiT), or MSCV-T-bet-
IRES-Thy1.1 (MIT-T-bet) were used to transduce established GFP
+
 DO11.10 Th2 cells 
two days after restimulation. Cells were then cultured under Th1 or Th2 conditions, 
followed by measurements of Ag-stimulated cytokine production or intracellular 
cytokines as above.    
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